molecules Molecules Molecules Molecules 1420-3049 MDPI 10.3390/molecules17089142 molecules-17-09142 Review Bioactivities of the Genus Combretum (Combretaceae): A Review de Morais Lima Gedson Rodrigues de Sales Igor Rafael Praxedes Caldas Filho Marcelo Ricardo Dutra de Jesus Neyres Zínia Taveira de Sousa Falcão Heloina Barbosa-Filho José Maria Cabral Analúcia Guedes Silveira Souto Augusto Lopes Tavares Josean Fechine Batista Leônia Maria * Department of Pharmaceutical Sciences, Federal University of Paraiba, João Pessoa 58051-970, PB, Brazil; Email: gedson@ltf.ufpb.br (G.R.M.L.); igor_caraubas@hotmail.com (I.R.P.S.); marcelo.dutra@ltf.ufpb.br (M.R.D.C.F.); neyresj@hotmail.com (N.Z.T.J.); heloinafalcao@yahoo.com.br (H.S.F.); jbarbosa@ltf.ufpb.br (J.M.B.-F.); analuciaguedes@gmail.com (A.G.S.C.); augustosouto@gmail.com (A.L.S.); josean@ltf.ufpb.br (J.F.T.) Author to whom correspondence should be addressed; Email: leoniab@uol.com.br; Tel.: +55-83-3216-7003; Fax: +55-83-3216-7502. 02 08 2012 08 2012 17 8 9142 9206 18 05 2012 23 07 2012 25 07 2012 © 2012 by the authors; licensee MDPI, Basel, Switzerland. 2012

This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).

The Combretaceae is a large family of herbs, shrubs and trees, comprising about 20 genera and 600 species with tropical distribution around the globe and centers of diversity in Africa and Asia. Some Combretum species are extensively used in traditional medicine against inflammation, infections, diabetes, malaria, bleeding, diarrhea and digestive disorders and others as a diuretic. The present work is a literature survey of Combretum species that have been evaluated for their ability to exert biological activities. A total number of 36 Combretum species are discussed with regard to plant parts used, component tested and bioassay models. This review is of fundamental importance to promoting studies on Combretum species, thereby contributing to the development of new therapeutic alternatives that may improve the health of people suffering from various health problems.

 Combretaceae Combretum bioactivity medicinal plants natural products review 1. Introduction

Medicinal plants have been used since ancient times in virtually all cultures as a source of medicines [1], and are of great importance to the health of individuals and communities [2]. Traditional medicine is used in all parts of the World and has a rapidly growing economic importance, mainly through the use of medicinal plants, especially in developing countries [3]. The medicinal use of plants of the family Combretaceae is widely described in the scientific literature [4,5,6]. This family is distributed in appoximately 20 genera with 600 species. The largest genera are Combretum and Terminalia, with about 370 and 200 species, respectively [7]. Members of the Combretaceae occur mainly in tropical and subtropical areas, for example, in Africa and Brazil.

Phytochemical Components Isolated from the Active Combretum Species

Phytochemical studies carried out in the genus Combretum have demonstrated the occurrence of many classes of constituents, including triterpenes, flavonoids, lignans and non-protein amino acids, among others [7]. Since the 1970s, several unusual compounds have also been isolated from Combretum species, for example, 9,10-dihydrophenanthrenes and a substituted bibenzyl from C. molle [8]. Bisoli et al. isolated 11 triterpenes and their glycosides from C. laxum, among them, oleanane-, ursane- and lupane-type such as arjunolic acid, arjunglucoside II, bellericoside, chebuloside II, quadranoside IV, asiatic acid and betulinic acid [9]. Cycloartane dienone lactone was isolated from C. quadrangulare [10], and alkaloids (combretine and betonicine) from the leaves of C. micranthum [11]. Some flavonoids, rhamnoctrin (Figure 1A), quercetin-5,3'-dimetylether (Figure 1B), ramnazin (Figure 1C) and kaempferol were isolated from C. erythrophyllum [12], as well as quercetrin, kaempferol and pinocembrin (flavanone) from C. apiculatum [13]. Cardamonin (chalcone) was also isolated from C. apiculatum [13] and ellagic acid derivatives from C. kraussii [14]. Combretastatins, a group of stilbenes, have been isolated from several species of Combretum [15].

As referenced above, there are several studies describing the phytochemistry of the species of this family, and the medicinal value of plants lies in the chemical substances that produce a physiological change in the human body [2]. Therefore, in continuation of our research on bioactive molecules from the various species of different plant families [16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47], the aim of this study was to review the literature on the bioactivity of the genus Combretum.

The molecular structures of compounds isolated from Combretum species.

 2. Results and Discussion

In this review, it was possible to list thirty-six species of the genus Combretum. The effectiveness of the plant extracts depended on the type of drug studied and the bioassay models. Thus, it was possible to classify the extracts as active or inactive. In this study, we chose more species referenced in data collected in the NAPRALERT natural products database and the scientific literature databases ScienceDirect and PubMed.

Combretum micranthum is a bushy shrub or creeper found all over Africa. C. micranthum is used in traditional medicine for the treatment of wounds and sores [48,49,50] and of fever (especially malaria fever), cough and bronchitis [49,51]. In studies evaluating its antibacterial activity, the extracts used were obtained with different solvents (ethanol, chloroform, methanol or water). Activity was observed against the following bacterial species: Pseudomonas aeruginosa, Staphylococcus aureus, Salmonella species, Streptococcus species, Proteus vulgaris, Klebsiella species, Sarcina lutea, Micrococcus luteus and Bacillus subtilis [52,53,54,55,56,57]. In addition, antifungal activity against Candida albicans was noted [56]. Antiviral activity of a methanolic extract was reported against Herpes simplex 1 and Herpes simplex 2 [58]. Toxicity studies have reported the activity of an ethanolic extract in the brine shrimp lethality test [56]. Benoit et al. [59] and Karou et al. [60] reported anti-Malarial activity against Plasmodium falciparum. However, a methanolic extract did not display cytotoxic activity aganist THP1 cells [61] (Table 1).

Di Carlo et al. [62] demonstrated immuno-stimulating activity with a suspension of powdered leaf. Chika and Bello [63] demonstrated an antidiabetic effect for the aqueous leaf extract of C. micranthum. A dose of 100 mg/kg of the extract was the most effective, among the doses tested. It produced a significant hypoglycemic and antidiabetic activity comparable to the effect of a standard drug (0.6 mg/kg glibenclamide) (Table 1). This study demonstrated the potential antidiabetic properties of aqueous leaf extract of C. micranthum for both type 1 and type 2 diabetes, justifying its traditional use in the treatment of this disease in Northwestern Nigeria. All of the above results contribute to justifying the use of the plant in traditional medicine for treating various conditions, particularly infections and diabetes.

C. molle (soft-leaved Combretum, velvet bush willow) is a tree with a larger, straighter trunk compared to most species of Combretum, further distinguished by its rough bark and dense crown. It occurs throughout tropical Africa and in the Arabian Peninsula in areas where woodlands and wooded grasslands predominate, often forming pure stands on hillsides [64].

C. molle has been widely used as a medicinal plant to treat various diseases such as parasitic, protozoan and other infectious diseases in East [65,66,67] and West Africa [68]. Antibacterial studies have demonstrated its activity against Staphylococcus aureus and Helicobacter pylori at different extract concentrations [69,70,71]. Antifungal activity was reported in models that used Epidermophyton floccosum, Microsporum gypseum, Trichophyton mentagrophytes, T. rubrum, Candida albicans, C. neoformans, Aspergillus fumigatus, Sporothrix schenckii and Microsporum canis [72,73]. C. molle was also able to inhibit the growth of Mycobacterium tuberculosis [74]. Antitrypansomal and anthelmintic activities of different extracts have also been reported [4,75,76,77] (Table 1).

Toxicity studies have reported the activity of aqueous and acetone extracts against Artemia salina [9]. Furthermore, Asres et al. [78] and Gansané et al. [6] reported antimalarial activity of the methanolic extract against Plasmodium falciparum at different concentrations tested. Molluscicidal effect of aqueous extract against Biomphalaria pfeifferi was also observed [75]. Meanwhile, embryotoxic effects have not been reported [79] (Table 1).

Methanolic extracts of the roots and leaves (25 μg/mL) of C. molle showed strong cytotoxic effects against T-24 bladder cancer cells [15]. In addition, the aqueous and methanol extracts of C. molle were screened for inhibitory effects against HIV-1 reverse transcriptase. These extracts produced relatively strong inhibition of RNA-dependent-DNA polymerase (RDDP) activity. The compounds responsible for these activities in this plant were not sought [80] (Table 1).

In the case of compounds obtained from C. molle, the analgesic and antiinflammatory properties of mollic acid glucoside (MAG) (Figure 1H), a 1α-hydroxycycloartenoid extracted from Combretum molle leaves, have been investigated in mice and rats [81]. The results of this laboratory animal study indicate that MAG possesses analgesic and antiinflammatory effects in the mammalian models used. The author suggested that MAG possesses both centrally- and peripherally-mediated analgesic effects.

Ojewole also reported on the cardiovascular effects of MAG. The results of this study showed that this compound was capable of causing bradycardia, vasorelaxation and hypotension in the animals evaluated [82]. In addition, hypoglycemic and antidiabetic activity have also been demonstrated [83].

In vitro anti-HIV activity of two isolated tannins from an acetone fraction, punicalgin (Figure 1F) and CM-A (whose structure has not yet been fully elucidated), was assessed against human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2). The results displayed selective inhibition of HIV-1 replication with selective indices (ratio of 50% cytotoxic concentration to 50% effective antiviral concentration) of 16 and 25, respectively and afforded complete cell protection against the virus-induced cytopathic effect when compared to control samples. Neither of the tannins was able to inhibit HIV-2 replication [84].

These results contribute to the validation of the popular use of this plant species in the treatment of bacterial, fungal, protozoan and viral infections and cardiovascular problems, among others.

The plant C. erythrophyllum (Burch.) Sond., commonly known as river Combretum, is a medium-sized, spreading, densely foliaged tree up to 12 m in height, which has been used by traditional healers for a variety of disorders [85,86]. C. erythrophyllum is widely used in traditional medical practice in southern Africa. It has been used for treating abdominal pains and venereal diseases, which suggests the presence of antibacterial compounds in the leaves [87].

As part of the treatment for venereal diseases, powdered roots of C. erythrophyllum are inserted into the vagina, which has resulted in several fatalities. The same procedure is followed to reduce the size of the vaginal orifice. In addition, the plant has been used to treat sexually transmitted diseases [85].

Extracts of C. erythrophyllum obtained with different solvents (acetone, hexane, chloroform, carbon tetrachloride and butanol) have shown antibacterial activity at different doses against Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus and Enterococcus faecalis [88,89] (Table 1). Some antibacterial flavonoids were subsequently isolated by bioassay-guided fractionation, namely genkwanin (Figure 1D), 5-hydroxy-7,4-dimethoxyflavone (Figure 1E), rhamnocitrin (Figure 1A), quercetin-5,3-dimethylether (Figure 1B), and rhamnazin (Figure 1C). These compounds showed good activity against Micrococcus luteus, Shigella sonei, Vibrio cholerae, Enterococcus faecalis and Pseudomonas aeruginosa. The results provide a clear rationale for the ethnomedicinal use of C. erythrophyllum leaves in treating bacterial infections [12]. Furthermore, these compounds have demonstrated antiinflammatory activity in experimental models in vitro [12].

Moreover, in studies evaluating antifungal activity, extracts obtained with different solvents (acetone, hexane, dichloromethane and methanol) were active against the following species: C. albicans, C. neoformans, A. fumigatus, S. schenckii and M. canis [73] (Table 1).

Toxicity studies have shown that the aqueous extract of C. erythrophyllum has mutagenic activity against Salmonella typhimurium [90]. The aqueous extract causes mutations in the meiotic stage of Drosophila melanogaster [86]. The methanol, dichloromethane and acetate extracts of C. erythrophyllum showed bioactivity in a yeast-based microtiter assay for DNA-damaging agents [91] (Table 1).

C. erythrophyllum extract has spasmolytic activity in the pre-contracted uterus, and this activity seems to involve the inhibition of cyclooxygenase, blocking the biosynthesis of prostaglandins, substances that are involved in uterine muscle contraction [92].

The alcoholic extract of Combretum dolichopetalum is used in folklore medicine to relieve stomach ache, blood in the stools, diarrhea, cramps and related gastrointestinal disorders [93]. The ethanolic extract of C. dolichopetalum has shown a gastroprotective effect in stress-induced and non-steroidal antiinflammatory (indomethacin)-induced ulcer models. The crude extract inhibited secretions induced in rats by pyloric ligation together with histamine [93,94] (Table 1). In addition, the pharmacological actions were evaluated in the guinea-pig isolated ileum and in intact rats. The crude extract inhibited the contractions induced by acetylcholine and histamine in the guinea-pig ileum in a concentration-dependent manner. The extract also delayed gastric emptying in rats in a dose-dependent manner. These results therefore suggest that C. dolichopetalum has gastric antisecretory activity, increasing gastric emptying time, and acts as a smooth muscle relaxant and spasmolytic agent [93,94] (Table 1).

The hepatoprotective effects of the ethanolic extract of C. dolichopetalum root bark were evaluated on paracetamol-induced liver intoxication in rats. Oral pre-treatment with C. dolichopetalum ethanolic extract significantly attenuated the elevation of serum glutamate-oxaloacetate transaminase (GOT) and glutamate- pyruvate transaminase (GPT) induced by paracetamol intoxication in rats [95] (Table 1).

Asuzu et al. [94] demonstrated that the methanol and chloroform extracts obtained with dried roots of C. dolichopetalum have antiinflammatory activity in models of carrageenan-induced paw edema and croton oil-induced edema in mice [96]. Udem et al. conducted toxicity studies in rats and found activity in both sexes (LD50 246.0 mg/kg) [97] (Table 1).

Combretum quadrangulare is a shrub or tree, indigenous to southeast Asia, especially Burma to Laos. The plant is commonly known as “tram bâu” (Vietnam), “kê khao” (Laos) or “sang kaê” (Cambodia), and the seeds are used in Vietnamese traditional medicine as a remedy against round and tapeworm infections in humans [98]. Studies conducted by Somanabandhu et al. [99] revealed the ether and ethanolic extracts of dried root bark or dried seed are effective against earthworms when tested in vitro [99]. Antimicrobial activity was also reported in extracts of dried leaves, which were active against Helicobacter pylori [100] (Table 1).

The hepatoprotective effect of MeOH, MeOH/H2O (1:1) and aqueous extracts of C. quadrangulare seeds were examined on D-galactosamine (D-GalN)/tumor necrosis factor-α (TNF-α)-induced cell death in primary cultured mouse hepatocytes. The MeOH extract showed the strongest inhibitory effect on D-GalN/TNF-α-induced cell death (IC50 56.4 μg/mL). Moreover, the MeOH extract also significantly lowered the serum GPT level in mice with D-GalN/lipopolysaccharide (LPS)-induced liver injury [101] (Table 1). Acetone, MeOH, and aqueous extracts of C. quadrangulare were tested for their trypanocidal activity against epimastigotes of Trypanosoma cruzi, the causative agent of Chagas disease. Strong trypanocidal activity was found in the acetone extract of C. quadrangulare [102] (Table 1).

The aqueous and EtOH extracts of C. quadrangulare were screened for their inhibitory activity against HIV-1 integrase (IN), an enzyme essential for viral replication. The aqueous and EtOH extracts showed significant inhibitory activity against HIV-1 with an IC50 value of 2.5 and 2.9 µg/mL, respectively [103] (Table 1). The compound O-galloyl-6-O-(4-hydroxy-3,5-dimethoxy)benzoyl-β-D-glucose (Figure 1G), a new gallic acid derivative isolated from C. quadrangulare, demonstrated potent hepatoprotective activity against D-GalN/TNF-alpha-induced cell death in primary cultured mouse hepatocytes [104]. The triterpenes of the lupane type, 2α,6β-dihydroxybetulinic acid (Figure 1I) and 6β-hydroxyhovenic acid (Figure 1J), isolated from the MeOH extract of C. quadrangulare seeds, also exhibited strong hepatoprotective activity [105].

 3. Material and Methods

The biological activity of the Combretum species was searched through the NAPRALERT (acronym for Natural Products ALERT) databank of the University of Illinois at Chicago. The data were updated in April 2011, using biological activity of the Combretum species as search term. The plant extracts were selected for this work and the references found in the search were later consulted for details on the models or mechanisms. Furthermore, this data survey was supplemented with searches in the PubMed and ScienceDirect sites. The specific names of the species were used as keywords.

molecules-17-09142-t001_Table 1

Bioactivities of drugs obtained of the genus botanical Combretum.

Biological Activity Botanical Name Part Tested Bioassay Models Result
Enzymatic activity
Inhibition of acetylcholinesterase
C. hartmannianum Schweinf. MeCl2 or AcOEt ext. of dried leaf In vitro-TLC and Microplate assay by Ellman’s method Inactive [106]
EtOH ext. of dried leaf In vitro-TLC and Microplate assay by Ellman’s method-IC50 for drug: 0.25 mg/mL Active [106]
MeCl2 and EtOH ext. of dried stem bark In vitro-TLC and Microplate assay by Ellman’s method-IC50 for drugs: 1.0 or 0.37 mg/mL, respectively Active [106]
AcOEt ext. of dried stem bark In vitro-TLC and Microplate assay Inactive [106]
EtOH ext. of dried root In vitro-TLC and Micro-plate assay by Ellman’s method-IC50 for drug: 0.37 mg/mL Active [106]
MeCl2 and AcOEt ext. of dried root In vitro-TLC and Microplate assay by Ellman’s method Inactive [106]
Inhibition of ACE
C. fruticosum (Loefl.) Stuntz MeOH/MeCl2 (50:50) ext. of dried stem or dried leaf In vitro-ACE isolated from rabbit lung catalyze the cleavage of the chromophore-fluorophore-labeled substract dansyltriglycine into dansylglycine—Concentration for drugs: 0.33 mg/mL Active [107]
EtOH ext. of leaves In vitro-ACE isolated from rabbit lung catalyze the cleavage of hippuryl-glycyl-glycine and react with trinitrobenzenesulfonic acid to form 2,4,6-trinitrophenyl glycyl glycine—Concentration for drug: 0.33 mg/mL Active [108,109]
Inhibition of topoisomerase
C. apiculatum Sond. subsp apiculatum EtOAc ext. of dried rootbark, or dried stemwood, or dried rootwood In vitro-Topoisomerase I or topoisomerase II inhibition assay after Polyvinylpyrrolidine (1:1) or Collagen (1:100) methods, respectively Active [110]
C. erythrophyllum (Burch.) Sond. EtOAc ext. of dried leaf In vitro-Topoisomerase I or topoisomerase II inhibition assay after Polyvinylpyrrolidine (1:1) or Collagen (1:100) methods, respectively Active [110]
Antiparasitic activity
Antiascariasis
C. quadrangulare Kurz. Ether and EtOH (95%) ext. of dried root bark or dried seed In vitro-Earthworms—Concentration not cited Active [99]
Antifilariasis
C. mucronatum Schumach. Hot H2O ext. of root 88 human adult infected with guinea worms—Dose for drug: 0.03 mg/kg (p.o.) Active [111]
Anthelmintic
C. apiculatum Sond. subsp. apiculatum H2O, Acetone and AcOEt ext. of dried leaf In vitro-Worms of Caenorhabditis elegans var. Bristol—Concentration for drugs: 0.5 and 1 mg/mL Active [112]
C. bracteosum (Hochst.) Brandis ex Engl. H2O, Acetone and AcOEt ext. of dried leaf In vitro-Worms of C. elegans var. Bristol—Concentration for drugs: 0.5 and 1 mg/mL Inactive [112]
C. celastroides Welw ex Laws subsp. celastroides H2O, Acetone and AcOEt ext. of dried leaf In vitro-Worms of C. elegans var. Bristol—Concentration for drugs: 0.5 and 1 mg/mL Inactive [112]
C. collinum Fresen. subsp. suluense (Engl. & Diels) Okafor H2O and AcOEt ext. of dried leaf In vitro-Worms of C. elegans var. Bristol—Concentration for drugs: 0.5 and 1 mg/mL Inactive [112]
Acetone ext. of dried leaf In vitro-Worms of C. elegans var. Bristol—Concentration for drugs: 0.5 and 1 mg/mL Active [112]
C. edwardsii Exell H2O, Acetone and AcOEt ext. of dried leaf In vitro-Worms of C. elegans var. Bristol—Concentration for drugs: 0.5 mg/mL Inactive [112]
Acetone and AcOEt ext. of dried leaf In vitro-Worms of C. elegans var. Bristol—Concentration for drugs: 1 mg/mL Active [112]
C. erythrophyllum (Burch.) Sond. H2O, Acetone and AcOEt ext. of dried leaf In vitro-Worms of C. elegans var. Bristol—Concentration for drugs: 0.5 mg/mL Inactive [112]
Acetone and AcOEt ext. of dried leaf In vitro-Worms of C. elegans var. Bristol—Concentration for drugs: 1 mg/mL Active [112]
C. hereroense Schinz H2O, Acetone and AcOEt ext. of dried leaf In vitro-Worms of C. elegans var. Bristol—Concentration for drugs: 0.5 mg/mL Inactive [112]
Acetone and AcOEt ext. of dried leaf In vitro-Worms of C. elegans var. Bristol—Concentration for drugs: 1 mg/mL Active [112]
C. imberbe Wawra H2O and AcOEt ext. of dried leaf In vitro-Worms of C. elegans var. Bristol—Concentration for drugs: 0.5 and 1 mg/mL Inactive [112]
Acetone ext. of dried leaf In vitro-Worms of C. elegans var. Bristol—Concentration for drugs: 1 mg/mL Active [112]
C. kraussii Hochst. H2O and AcOEt ext. of dried leaf In vitro-Worms of C. elegans var. Bristol—Concentration for drugs: 0.5 and 1 mg/mL Inactive [112]
Acetone ext. of dried leaf In vitro-Worms of C. elegans var. Bristol—Concentration for drugs: 0.5 and 1 mg/mL Active [112]
C. microphyllum Klotzsch H2O and AcOEt ext. of dried leaf In vitro-Worms of C. elegans var. Bristol—Concentration for drugs: 0.5 and 1 mg/mL Inactive [112]
Acetone ext. of dried leaf In vitro-Worms of C. elegans var. Bristol—Concentration for drugs: 0.5 and 1 mg/mL Active [112]
C. mkuzense Carr & Retief H2O and AcOEt ext. of dried leaf In vitro-Worms of C. elegans var. Bristol—Concentration for drugs: 0.5 and 1 mg/mL Inactive [112]
Acetone ext. of dried leaf In vitro-Worms of C. elegans var. Bristol—Concentration for drugs: 0.5 and 1 mg/mL Active [112]
C. moggii Exell H2O, Acetone and AcOEt ext. of dried leaf In vitro-Worms of C. elegans var. Bristol—Concentration for drugs: 0.5 and 1 mg/mL Inactive [112]
C. molle R. Br. ex G. Don H2O and AcOEt ext. of dried leaf In vitro-Worms of C. elegans var. Bristol—Concentration for drugs: 0.5 and 1 mg/mL Inactive [112]
Acetone ext. of dried leaf In vitro-Worms of C. elegans var. Bristol—Concentration for drugs: 0.5 and 1 mg/mL Active [112]
Acetone ext., n-butanol, hexane, CHCl3 or H2O/MeOH fractions of leaf In vitro-Nematocidal activity by means of an egg hatch and larval development of Haemonchus contortus-Lethal Concentration 50% (LC50) for drugs: 0.866, 0.333, 0.833, 0.747 or 0.065 mg/mL, respectively Active [77]
In vitro-Nematocidal activity by means of an egg hatch and larval development of Haemonchus contortus-Lethal Concentration 50% (LC50) for drugs: 0.604, 0.362, 1.077, 0.131 or 0.318 mg/mL, respectively Active [77]
H2O/MeOH ext. Lambs infected with larvae of H. contortus—Dose for drug: 500, 1,000 or 2,000 mg/kg (p.o.) Active [113]
C. mossambicense (Klotzsch) Engl. H2O, Acetone and AcOEt ext. of dried leaf In vitro-Worms of C. elegans var. Bristol—Concentration for drugs: 0.5 mg/mL Inactive [112]
Acetone and AcOEt ext. of dried leaf In vitro-Worms of C. elegans var. Bristol—Concentration of drugs: 1 mg/mL Active [112]
C. mucronatum Schumach. Hot H2O ext Human adult infected with guinea worms—Dose not cited: (p.o.) Active [114]
C. nelsonii Dümmer H2O and AcOEt ext. of dried leaf In vitro-Worms of C. elegans var. Bristol—Concentration for drugs: 0.5 and 1 mg/mL Inactive [112]
Acetone ext. of dried leaf In vitro-Worms of C. elegans var. Bristol—Concentration for drugs: 0.5 and 1 mg/mL Active [112]
C. nigricans Lepr. MeCl2/MeOH ext. or H2O ext. of fruit Motility warms of Caenorhabditis elegans Bristol—Concentration for drugs: 1 mg/mL Active [115]
C. padoides Engl. & Diels H2O, Acetone and AcOEt ext. of dried leaf In vitro-Worms of C. elegans var. Bristol—Concentration for drugs: 0.5 and 1 mg/mL Inactive [112]
C. paniculatum Vent. H2O and AcOEt ext. of dried leaf In vitro-Worms of C. elegans var. Bristol—Concentration for drugs: 0.5 and 1 mg/mL Inactive [112]
Acetone ext. of dried leaf In vitro-Worms of C. elegans var. BristolConcentration for drugs: 0.5 and 1 mg/mL Active [112]
C. petrophilum Retief H2O and AcOEt ext. of dried leaf In vitro-Worms of C. elegans var. Bristol—Concentration for drugs: 0.5 and 1 mg/mL Inactive [112]
Acetone ext. of dried leaf In vitro-Worms of C. elegans var. Bristol—Concentration for drugs: 0.5 and 1 mg/mL Active [112]
C. woodii Dümmer H2O, Acetone and AcOEt ext. of dried leaf In vitro-Worms of C. elegans var. Bristol—Concentration for drugs: 0.5 and 1 mg/mL Inactive [112]
C. zeyheri Sond. H2O, Acetone and AcOEt ext. of dried leaf In vitro-Worms of C. elegans var. Bristol—Concentration for drugs: 0.5 and 1 mg/mL Inactive [112]
Antileishmaniasis
C. comosum G. Don. MeOH, MeOH/H2O (50:50) or MeCl2 ext. of dried leaves In vitro-Promastigotes of Leishmania infantum—Concentration for all drugs: >100.0 μg/mL Inactive [116]
C. cuspidatum Planch. ex Benth. MeOH, MeOH/H2O (50:50) or MeCl2 ext. of dried leaves In vitro-Promastigotes of L. infantum—Concentration for drugs: 34.5, >100.0 or 43.5 μg/mL, respectively Inactive [116]
MeOH, MeOH/H2O (50:50) or MeCl2 ext. of stem barks In vitro-Promastigotes of L. infantum—Concentration for drugs: >100.0, >100.0 or 28.6 μg/mL, respectively Inactive [116]
C. molle R. Br. ex G. Don Acetone fraction of stembark In vitro—Murine peritoneal macrophages infected with amastigotes of L. donovani—Concentration for drug: 30.0 μg/mL Inactive [76]
Antimalarial
C. micranthum G. Don. EtOH (95%) ext. of dried leaf In vitro-Cell culture (erythrocytes) with parasite maturation of Plasmodium falciparum—IC50 for drug: 33.05 μg/mL Active [60]
MeOH ext. of dried leaf In vitro-Cell culture (P. falciparum W2)—Concentration for drug: >25 μg/mL Inactive [61]
Decoction or infusion of dried leaf and stem In vitro-Cell culture (P. falciparum FcB1-Colombia chloroquine resistant)—IC50 for drug: 1.18 μg/mL Active [59]
Infusion of dried leaf and stem In vitro-Cell culture (P. falciparum F32-Tanzania chloroquine-sensitive)—IC50 for drug: 1.7 μg/mL Active [59]
Decoction of dried leaf and stem In vitro-Cell culture (P. falciparum F32-Tanzania chloroquine-sensitive)—IC50 for drug: 0.88 μg/mL Active [59]
C. molle R. Br. ex G. Don Acetone fraction of stem bark In vitro-Cell culture (Trophozoites of P. falciparum)—IC50 for drug: 8.17 μg/mL Active [76]
MeOH ext. of dried stem In vitro-Cell culture with P. falciparum—IC50 for drug: 1.25 μg/mL Active [78]
EtOH (90%) ext. of leaves, rootbark or stembark In vitro-Cell culture with P. falciparum K1—IC50 for drugs: 4.0 μg/mL Active [4]
MeOH or MeOH/H2O ext. of leaves In vitro-Cell culture (K562S human monocyte infected with P. falciparum W2)-IC50 for drugs: 5.7 or 7.9 μg/mL, respectively Active [6]
C. aff. psidioides Welw. subsp.psilophyllum Wickens EtOH (95%), Pet ether, EtOAc or H2O ext. of dried root bark In vitro—Microdiluition assay (P. falciparum)—IC50 for drugs: 31.0, 39.0, 6.5or 30.0 μg/mL, respectively Active [117]
C. racemosum P. Beauv EtOH (90%) ext. of leaves or root bark In vitro-Cell culture with P. falciparum K1—IC50 for drug: 4.0 μg/mL Active [4]
C. zeyheri Sond. MeCl2/MeOH (1:1) or H2O ext. of twigs In vitro—Microdiluition assay (P. falciparum D10)—Concentration for drug: 15 or >100 μg/mL, respectively Inactive [118]
Antischistosomal
C. aculeatum Vent. H2O ext. of dried leaf In vitro—Miracidicidal and cercaricidal activity on Schistosoma mansoni—Concentration for drug: 1,000 ppm Active [119]
C. apiculatum Sond. subsp. apiculatum H2O ext. of dried leaf In vitro-Worms of Schistosoma haematobium—Concentration not cited Inactive [112]
C. bracteosum (Hochst.) Brandis ex Engl. H2O ext. of dried leaf In vitro-Worms of S. haematobium—Concentration not cited Inactive [112]
C. celastroides Welw ex Laws subsp. celastroides H2O ext. of dried leaf In vitro-Worms of S. haematobium—Concentration not cited Inactive [112]
In vitro—Miracidicidal and cercaricidal activity on S. mansoni—Concentration for drug: 1,000 ppm Active [119]
C. edwardsii Exell H2O ext. of dried leaf In vitro-Worms of S. haematobium—Concentration not cited Inactive [112]
C. erythrophyllum (Burch.) Sond. H2O ext. of dried leaf In vitro-Worms of S. haematobium—Concentration not cited Inactive [112]
C. glutinosum Perrot. ex DC H2O ext. of dried leaf In vitro-Miracidicidal and cercaricidal activity on S. mansoni-Concentration for drug: 1,000 ppm Active [119]
C. hartmannianum Schweinf. H2O ext. of dried leaf In vitro-Miracidicidal and cercaricidal activity on S. mansoni-Concentration for drug: 1,000 ppm Active [119]
C. hereroense Schinz H2O ext. of dried leaf In vitro-Worms of S. haematobium-Concentration not cited Inactive [112]
C. imberbe Wawra H2O ext. of dried root or dried leaf In vitro-Worms of S. haematobium—MIC for drugs: 25.0 or 12.5 mg/mL, respectively Active [112,120]
C. kraussii Hochst. H2O ext. of dried leaf In vitro-Worms of S. haematobium—MIC for drug: 12.5 mg/mL Active [112]
C. microphyllum Klotzsch H2O ext. of dried leaf In vitro-Worms of S. haematobium—Concentration not cited Inactive [112]
C. mkuzense Carr & Retief H2O ext. of dried leaf In vitro-Worms of S. haematobium—Concentration not cited Inactive [112]
C. moggii Exell H2O ext. of dried leaf In vitro-Worms of S. haematobium—Concentration not cited Inactive [112]
C. molle R. Br. ex G. Don H2O ext. of dried leaf In vitro-Worms of S. haematobium—MIC for drug: 25 mg/mL Active [112]
C. mossambicense (Klotzsch) Engl. H2O ext. of dried leaf In vitro-Worms of S. haematobium—Concentration not cited Inactive [112]
C. nelsonii Dümmer H2O ext. of dried leaf In vitro-Worms of S. haematobium—MIC for drug: 12.5 mg/mL Active [112]
C. padoides Engl. & Diels H2O ext. of dried leaf In vitro-Worms of S. haematobium—Concentration not cited Inactive [112]
C. paniculatum Vent. H2O ext. of dried leaf In vitro-Worms of S. haematobium—MIC for drug: 25 mg/mL Active [112]
C. petrophilum Retief H2O ext. of dried leaf In vitro-Worms of S. haematobium—MIC for drug: 25 mg/mL Active [112]
C. woodii Dümmer H2O ext. of dried leaf In vitro-Worms of S. haematobium—Concentration not cited Inactive [112]
C. zeyheri Sond. H2O ext. of dried leaf In vitro-Worms of S. haematobium—Concentration not cited Inactive [112]
Antitrypanosomal
C. dolichopetalum Gils ex Engl. EtOH (70%) ext. of dried root bark Infection induced in rats (Trypanosoma brucei or Trypanosoma congolense )—Dose for drug: 80.0 mg/kg (i.p.) Active [97]
C. molle R. Br. ex G. Don Acetone fraction of stem bark In vitro—Murine peritoneal macrophages infected with Trypanosoma cruzi—Concentration for drug: >12.0 μg/mL Inactive [76]
In vitro-Blood stream form trypomastigotes of T. brucei rhodesiense—IC50 for drug: 2.19 μg/mL Active [76]
EtOH (90%) ext. of leaves, root bark or stem bark In vitro—Blood stream form trypomastigotes of T. brucei rhodesiense—Concentration for drugs: >25 μg/mL Inactive [4]
H2O ext. of leaves In vitro-Blood stream form trypomastigotes of T. brucei rhodesiense—IC50 for drug: 10 μg/mL Active [121]
C. quadrangulare Kurz. Acetone ext. of dried leaf In vitro-Epimastigotes of T. cruzi-IC50 for drug: 6.25 μg/mL Active [102]
MeOH or H2O ext. of dried leaf In vitro-Epimastigotes of T. cruzi—Concentration for drugs: 100.0 μg/mL Inactive [102]
C. racemosum P. Beauv EtOH (90%) ext. of leaves or of root bark In vitro-Blood stream form trypomastigotes of T. brucei rhodesiense—Concentration for drugs: >25 μg/mL Inactive [4]
Larvicidal-Dengue fever
C. aculeatum Vent. MeCl2, MeOH and H2O ext. of dried leaf or dried root bark In vitro-Larvae of Aedes aegypti—Concentration for drugs: 500.0 μg/mL or 500.0 ppm Inactive [122]
MeOH and H2O ext. of dried stem In vitro-Larvae of A. aegypti—Concentration for drugs: 500.0 ppm Inactive [122]
C. collinum Fresen. Ether ext. of shoot bark In vitro-Larvae of A. aegypti—Concentration for drug: 0.0125–0.200 mg/mL Active [123]
Antimicrobial activity
Antibacterial
C. apiculatum Sond. ssp. apiculatum Hexane ext. of dried leaf Microdilution assay (Bacillus subtilis, Escherichia coli, Staphylococcus aureus or Klebisiella pneumoniae)—Maximum concentration for drug: 12.5 mg/mL Inactive [65]
EtOH ext. of dried leaf Microdilution assay (B. subtilis or S. aureus with MIC for drug: 0.049 mg/mL) Active [65]
Microdilution assay (K. pneumonia or E. coli)—Maximum concentration for drug: 12.5 mg/mL Inactive [65]
H2O ext. of dried leaf Microdilution assay (B. subtilis or S. aureus with MIC for drug: 0.39 mg/mL ) Active [65]
Microdilution assay (K. pneumonia or E. coli)—Maximum concentration for drug: 12.5 mg/mL Inactive [65]
C. bracteatum (Laws.) Engl. et Diels EtOH (40%) or H2O ext. of dried stem Agar diffusion method (E. coli, Nisseria gonorrheae, S. aureus, Streptococcus sp, Salmonella typhimurium, B. subtilis, Bacteroides melaninogenicus, Clostridium tetani, Proteus vulgaris, Pseudomonas pyocyanea, Shgella dysenteriae or Yersinia enterocolita)—Concentration for drugs: 0.33 g/mL Inactive [124]
Agar diffusion method (K. pneumoniae or Bacteroides fragilis)—Concentration for drugs: 0.33 g/mL with 5–9 mm diameter zone of inhibition Active [124]
EtOH (40%) ext. of dried stem Agar diffusion method (Corynebacterium diphtheriae)—Concentration for drug: 0.33 g/mL Inactive [124]
H2O ext. of dried stem Agar diffusion method (C. diphtheriae)—Concentration for drug: 0.33 g/mL with 5–9 mm diameter zone of inhibition Active [124]
C. collinum Fresen. MeOH, EtOH or MeOH-H2O ext. of dried air parts Agar diffusion method with diameters inhibition zones (Pseudomonas aeruginosa)—Concentraton for drugs: 1 and 5 mg/mL with inhibition of 9 mm Active [57]
Agar diffusion method with diameters inhibition zones (E. coli, K. pneumoniae, Citrobacter freundii, S. aureus, Streptococcus pyogenes, Listeria monocytogenes or B. subtilis)—Concentraton for drugs: 1 and 5 mg/mL Inactive [57]
C. comosum G. Don. Hot H2O ext. of dried root bark Agar diffusion method with diameters inhibition zones (Mycobacterium phlei, Sarcina lutea or S. aureus)—Concentration not cited. Active [52]
C. erythrophyllum (Burch.) Sond. Acetone ext. of dried leaf Microdilution assay—(S. aureus, P. aeruginosa, Enteroccus faecalis or E. coli)—IC50 for drug: 1.50, 1.50,1.50 or 0.8 mg/mL, respectively Active [89]
Acetone, EtOH (100%), CHCl3/MeOH/H2O (12:5:3), H2O, MeCl2 or MeOH ext. of dried leaf Diluition and bioautographic TLC system assay (S. aureus)—Concentration for drugs: 0.1 g/mL Active [125]
CHCl3 or CCl4 ext. of freeze-dried leaf Microdilution assays [(S. aureus, MIC for drugs: 0.1or 1.6 mg/mL, respectively), (E. faecalis, MIC for drugs: 0.2 or 1.6 mg/mL, respectively), (E. coli, MIC for drugs: 3.1 or 12.5 mg/mL, respectively) and (P. aeruginosa, MIC for drugs: 3.1 or 25.0 mg/mL, respectively)] Active [88]
H2O or MeOH/H2O (2:1) ext. of freeze-dried leaf Microdilution assays [(S. aureus, MIC for drugs: 0.2 or 0.05 mg/mL, respectively), (E. faecalis, MIC for drugs: 0.4 mg/mL), (E. coli, MIC for drugs: 1.6 or 6.3 mg/mL, respectively), (P. aeruginosa, MIC for drugs: 6.3 or 12.5 mg/mL, respectively)] Active [88]
Butanol or Hexane ext. of freeze-dried leaf Microdilution assays [(S. aureus, MIC for drugs: 0.4 or 50 mg/mL, respectively), (E. faecalis, MIC for drugs: 0.2 or 1.6 mg/mL, respectively), (E. coli, MIC for drugs: 25 or 0.8 mg/mL, respectively), (P. aeruginosa (MIC for drugs: 12.5 or 1.6 mg/mL, respectively)] Active [88]
CHCl3 fraction of leaves Serial dilution microplate assay (Micrococcus luteus, Shigella sonnei, Vibrio cholera or E. faecalis—MIC for drug: 50, 25, 50 or 50 μg/mL, respectively) Active [12]
C. glutinosum Perrot. ex DC. MeOH ext. of dried leaf Agar diffusion method ( S. lutea and E. coli —Concentration for drug:15.0 and 10.0 mg/mL, respectively) Active [53]
C. hartmannianum Schweinf. MeCl2, EtOAc or EtOH ext. of dried leaf Microdilution assay (B. subtilis)—MIC for drugs: <0.1, 0.39 or 0.2 mg/mL, respectively Active [106]
Microdilution assay (K. pneumonia)—MIC for drugs: 0.2, 0.78 or 0.39 mg/mL, respectively Active [106]
Microdilution assay (S. aureus)—MIC for drugs: 1.56, 1.56 or 0.2 mg/mL, respectively Active [106]
Microdilution assay (E. coli)—MIC for drugs: 1.56, 1.56 or 0.39 mg/mL, respectively Active [106]
MeCl2, EtOAc or EtOH ext. of dried bark Microdilution assay (K. pneumonia)—MIC for drugs: 0.39, 0.78 or 0.78 mg/mL, respectively Active [106]
Microdilution assay (Staphylococcus aureus)—MIC for all drugs: 3.13 mg/mL Active [106]
Microdilution assay (E. coli)—MIC for drugs: 3.13, 3.13 or 1.56 mg/mL, respectively Active [106]
Microdilution assay (B. subtilis)—MIC for drugs: 3.13, 0.39 or 1.56 mg/mL, respectively Active [106]
Microdilution assay (K. pneumonia)—MIC for drugs: 0.78, 0.78 or 0.2 mg/mL, respectively Active [106]
Microdilution assay (B. subtilis)—MIC for drugs: 0.1, 0.39 or 0.39 mg/mL, respectively Active [106]
Microdilution assay (S. aureus)—MIC for all drugs: 3.13, 3.13 or 0.2 mg/mL, respectively Active [106]
Microdilution assay (E. coli)—MIC for drugs: 3.13, 3.13 or 0.2 mg/mL, respectively Active [106]
Broth microdilution method (Mycobacterium aurum A+)—MIC for drugs: 0.78, 3.12 or 0.19 mg/mL, respectively Active [126]
Broth microdilution method (M. aurum A+)—MIC for drugs: 12.5, 25 or 1.56 mg/mL, respectively Active [126]
MeCl2 or EtOH ext. of dried root Broth microdilution method (M. aurum A+)—MIC for drugs: 3.12 or 12.5 mg/mL, respectively Active [126]
EtOAc ext. of dried root Broth microdilution method (M. aurum A+)—Concentration for drug: 25 mg/mL Inactive [126]
C. imberbe Wawra MeCl2 ext. of dried leaves Microplate serial dilution method (S. aureus)—Concentration for drug: 39 μg/mL Active [127]
C. micranthum G. Don Hot H2O ext. of dried root Agar diffusion method (Mycobacterium phlei)—Concentration not cited. Inactive [52]
MeOH, EtOH or MeOH-H2O ext. of dried air parts Agar diffusion method with diameters inhibition zones (P. aeruginosa)—Concentration for drugs: 1 and 5 mg/mL with inhibition zone of 9 or 8 mm Active [57]
Agar diffusion method with diameters inhibition zones (S. pyogenes, L. monocytogenes)—Concentration for drugs: 1 mg/mL Inactive [57]
Agar diffusion method with diameters inhibition zones (E. coli, K. pneumoniae, C. freundii or B. subtilis)—Concentration for drugs: 1 and 5 mg/mL Inactive [57]
Agar diffusion method with diameters inhibition zones or microdilution assay (S. aureus)—Concentration for drugs: 1 and 5 mg/mL with inhibition zone of 10 mm, or MIC for drugs: 0.5 µg/mL Active [57]
EtOH (95%) ext. of dried twigs Agar diffusion method with diameters inhibition zones (B. subtilis or S. aureus)—Concentration for drug: 50 mg/mL with inhibition zone > 15 mm or 5 mg/mL with inhibition zone > 15 mm Active [49]
EtOH (100%) ext. of dried leaf Microplate serial dilution method [Salmonella sp, Streptococcus sp, P. vulgaris, S. aureus, E. coli, P. aeruginosa or Klebsiella sp—MIC for drug: 1.0 mg/mL] Active [56]
CHCl3 ext. of dried leaf Microplate serial dilution method [Salmonella sp, E. coli, P. aeruginosa, Klebsiella sp—Concentration for drug: 1.0 mg/mL] Inactive [56]
Microplate serial dilution method [Streptococcus sp, P. vulgaris or S. aureus—MIC for drug: 1.0 mg/mL] Active [56]
H2O ext. of dried leaf Microplate serial dilution method [Salmonella sp, P. aeruginosa or S. aureus—MIC for drug:1.0 mg/mL] Active [56]
Microplate serial dilution method [E. coli, Klebsiella sp, Streptococcus sp. or P. vulgaris—Concentration for drug: 1.0 mg/mL] Inactive [56]
MeOH ext. of dried leaf Microplate serial dilution method (S. lutea or E. coli)—MIC for drug: 10.0 mg/mL Active [53]
Hot H2O ext. of dried root Microplate serial dilution method [S. lutea or S. aureus]—Concentration not cited. Active [52]
Microplate serial dilution method (C. diphtheria)—MIC for drug: 5.0 mg/mL Active [55]
H2O ext. of dried root Microplate serial dilution method (Serratia marcescens or Salmonella typhosa )-MIC for drug: 5.0 or 3.0 mg/mL, respectively Active [55]
Decoction of dried root Microplate serial dilution method (L. monocytogenes, E. faecalis, S. marcescens, S. typhosa or C. diphtheria)—MIC for drug: 7.0, 7.0, 5.0, 3.0 or 3.0 mg/mL, respectively Active [55]
Decoction or H2O ext. of dried root Microplate serial dilution method [K. pneumonia (MIC 5.0 mg/mL or 7.0 mg/mL, respectively); S. aureus ( MIC 1.0 mg/mL or 2.0 mg/mL, respectively)] Active [55]
H2O ext. of dried root Microplate serial dilution method [L. monocytogenes ( MIC > 10.0 mg/mL), E. faecalis ( MIC > 10.0 mg/mL) Inactive [55]
Decoction or H2O ext. of dried root Microplate serial dilution method [M. luteus, P. aeruginosa, E. coli or B. subtilis)—MIC for drug: 1.0, 5.0, 5.0, 5.0 or 5.0 mg/mL, respectively Active [55]
EtOH (100%) ext. of dried stembark Microplate serial dilution method (Salmonella sp, E. coli, P. vulgaris or Klebsiella sp)—Concentration for drug: >1.0 mg/mL Inactive [56]
Microplate serial dilution method (P. aeruginosa, S. aureus or Streptococcus sp)—MIC for drug:1.0 mg/mL Active [56]
EtOH (95%) ext. of sun dried twig Microplate serial dilution method (B. subtilis or S. aureus)—MIC for drug: 50.0 or 5.0 mg/mL, respectively) Active [54]
C. molle R.Br. ex G. Don. Acetone and H2O ext. of dried bark In vitro-Radiometric method (M. tuberculosis)—MIC for drugs: 1.0 mg/mL Active [74]
Acetone fraction of dried stem bark Microdilution method (M. tuberculosis typus humanus)—Concentration for drug: 1.0–2 mg/mL Inactive [128]
MeOH ext. of dried bark Microdilution method (Streptococcus mutans or Actinomyces viscosus)-MIC for drug:5.0 mg/mL Active [129]
Acetone ext. of dried leaf Microdilution method (S. aureus)—MIC for drug: 0.07 mg/mL Active [69]
Acetone ext. of dried stembark Agar diffusion method (S. aureus)—Concentration for drug: 1.0 mg/mL Active [128]
MeOH ext. of dried wood Agar diffusion method (S. mutans)—Concentration for drug: 5.0 mg/disc Inactive [129]
Agar diffusion method (A. viscosus)—Concentration for drug: 5.0 mg/disc Active [129]
Acetone ext. of stem bark Agar diffusion and micro broth dilution methods (Helicobacter pylori)—Concentration for drug: 100 mg/mL with inhibition zone of 10–38 mm, and MIC for drug: 0.08–2.50 mg/mL Active [71]
EtOH or MeOH ext. of stem bark Agar diffusion method and micro broth dilution methods (H. pylori)—Concentration for drug: 100 mg/mL with inhibition zone of 7–35 or 7–32 mm Active [71]
AcOEt or H2O ext. of stem bark Agar diffusion and micro broth dilution methods (H. pylori)—Concentration for drug: 100 mg/mL with inhibition zone of 0–21 or 0–20 mm Active [71]
EtOH ext. of stem bark Agar dilution method (Bacillus cereus or S. aureus)—MIC for drug: 250 μg/mL Active [70]
MeOH ext. of dried root Plate-hole diffusion and broth microdilution (S. aureus)—MIC for drug: 1 mg/mL Active [130]
Plate-hole diffusion and broth microdilution (S. epidermidis)—Concentration for drug: 1 mg/mL Inactive [130]
H2O ext. of dried root Plate-hole diffusion and broth microdilution (S. epidermidis or S. aureus)—Concentration for drug: 1 mg/mL Inactive [130]
EtOH ext. of dried seed or stem Agar plate with diameters inhibition zones—S. aureus—Concentration for drugs: 100 or 50 mg/mL with inhibition zone of 5 mm Active [131]
EtOH ext. of dried bark or leaf Agar plate with diameters inhibition zones—S. aureus—Concentration for drugs: 3–100 mg/mL with inhibition zone of 20 mm Active [131]
EtOH ext. of dried leaf Agar plate with diameters inhibition zones—S. agalactiae—Concentration for drug: 50 mg/mL with inhibition zone of 20 mm Active [131]
C. paniculatum Vent. EtOH (80%) ext. of dried leaf Microdilution method (M. tuberculosis)—Concentration for drug: 2 mg/mL Inactive [128]
Acid-EtOH ext. of dried leaf Agar plate well-diffusion method (S. aureus, Salmonella gallinarum, E. coli, P. vulgaris, P. aeruginosa, K. pneumonia)—Concentration for drug: 0.20 mL/disc (1,000 µg/mL) Active [132]
H2O ext. of dried leaf Agar plate well-diffusion method (S. aureus, E. coli, P. vulgaris or K. pneumonia)—Concentration for drug: 0.20 mL/disc (1,000 µg/mL) Active [132]
Agar plate well-diffusion method (S. gallinarum or P. aeruginosa)—Concentration for drug: 0.20 mL/disc (1,000 µg/mL) Inactive [132]
MeOH ext. of dried root Plate-hole diffusion and broth microdilution—S. epidermidis (MIC for drug: 2.77 mg/mL) or S. aureus (MIC for drug: 1.85 mg/mL) Active [130]
H2O ext. of dried root Plate-hole diffusion and broth microdilution—S. epidermidis or S. aureus (MIC for drug: 14.44 mg/mL) Active [130]
C. quadrangulare Kurz. MeOH or H2O ext. of dried leaf Agar plate well-diffusion method (H. pylori)—Concentration not cited Active [100]
EtOH (95%) ext. of dried seed or dried root Agar plate well-diffusion method (several gram + organisms)—Concentration not cited Active [99]
C. racemosum P. Beauv. EtOH (40%) or H2O ext. of dried petiole and leaves Agar plate diffusion method (E. coli, N. gonorrheae, Streptococcus sp, B. subtilis, P. vulgaris, P. pyocyanea, K. pneumoniae, B. fragilis, Y. enterocolita or S. typhimurium)—Concentration for drugs: 0.33 g/mL Inactive [124]
EtOH (40%) ext. of dried petiole and leaves Agar plate diffusion method (S. aureus)—Concentration for drugs: 0.33 g/mL with ≥ 20 mm diameter zone of inhibition Active [124]
EtOH (40%) ext. of dried leaf and stem Agar plate diffusion method (C. diphtheria, B. melaninogenicus or S. dysenteriae)—Concentration for drugs: 0.33 g/mL with ≥ 20 mm diameter zone of inhibition Active [124]
Agar plate diffusion method (C. tetani)—Concentration for drugs: 0.33 g/mL with 10–19 mm diameter zone of inhibition Active [124]
H2O ext. of dried petiole and leaves Agar plate diffusion method (C. tetani)—Concentration for drugs: 0.33 g/mL Inactive [124]
C. raimbaultii Heckel EtOH/H2O (1:1) ext. Agar plate diffusion method (E. coli or S. aureus)—Concentration not cited Active [133]
Agar plate diffusion method (B. anthracis)—Concentration not cited Inactive [133]
C. zeyheri Sond. H2O ext. of fresh entire plant Agar plate diffusion method (N. gonorrhea)—Concentration for drugs: 1.0 mg/mL Inactive [134]
Antifungal
C. aculeatum Vent. CHCl3, MeOH or H2O ext. of dried leaf or dried stem Agar plate diffusion method (Candida albicans)—Concentration not cited Active [135]
MeOH, H2O or CHCl3 ext. of dried leaf or dried stem Agar plate diffusion method (Aspergillus niger)—Concentration for drugs: 1 mg/mL Active [135]
MeCl2, MeOH or H2O ext. of dried leaf, dried root bark or dried stem Agar plate diffusion method (Cladosporium cucumerinum)—Concentration for drugs: 100.0 μg/plate Inactive [122]
C. acutifolium Exell Acetone, Hexane, MeCl2 or MeOH ext. of dried leaf Microdilution assay [C. albicans—MIC for drugs: 0.16, 2.5, 2.5 or 0.04 mg/mL, respectively; Criptococcus neoformans—MIC for drugs: 0.04, 0.16, 0.16 or 0.08 mg/mL, respectively] Active [73]
Microdilution assay [Aspergillus fumigates—MIC for drugs: 0.08, 2.5, 0.16 or 0.16 mg/mL, respectively; Sporothrix schenckii—MIC for drugs: 0.04, 0.32, 0.32 or 0.08 mg/mL, respectively; Microsporum canis—MIC for all drugs: 0.02 mg/mL] Active [73]
C. apiculatum Sond. ssp. apiculatum Acetone, Hexane, MeCl2 or MeOH ext. of dried leaf Microdilution assay [A. fumigates—MIC for all drugs: 2.5 mg/mL; M. canis—MIC for all drugs: 0.02 mg/mL] Active [73]
Microdilution assay [S. schenckii—MIC for drugs: 0.02, 0.04, 0.02 or 0.02 mg/mL, respectively; C. neoformans—MIC for drugs: 0.08, 2.5, 0.08 or 0.08 mg/mL, respectively] Active [73]
Microdilution assay (C. albicans)—MIC for drugs: 0.32, 1.25, 0.32 or 0.32 mg/mL, respectively Active [73]
C. albopuctatum Acetone, Hexane, MeCl2 or MeOH ext. of dried leaf Microdilution assay (C. albicans)—MIC for drugs: 0.64, 2.5, 0.32or 0.32 mg/mL, respectively Active [73]
Microdilution assay (C. neoformans)—MIC for drugs: 0.08, 0.08, 0.16 or 0.16 mg/mL, respectively Active [73]
Microdilution assay (A. fumigates)—MIC for drugs: 0.08, 0.64, 0.16 or 0.32 mg/mL, respectively Active [73]
Microdilution assay (S. schenckii)—MIC for all drugs: 0.02 mg/mL Active [73]
Microdilution assay (M. canis)—MIC for drugs: 0.02, 0.02, 0.02 or 0.04 mg/mL, respectively Active [73]
C. bracteosum (Hochst.) Brandis ex Engl. Acetone, Hexane, MeCl2 or MeOH ext. of dried leaf Microdilution assay (C. albicans)—MIC for drugs: 1.25, 2.5, 2.5 or 1.25 mg/mL, respectively Active [73]
Microdilution assay (C. neoformans)—MIC for drugs: 0.16, 0.16, 0.32 or 0.32mg/mL, respectively Active [73]
Microdilution assay (A. fumigates)—MIC for all drugs: 2.5 mg/mL Active [73]
Microdilution assay (S. schenckii)—MIC for drugs: 0.16, 0.08, 0.16 or 0.16 mg/mL, respectively; M. canis—MIC for all drugs: 0.02 mg/mL Active [73]
C. caffrum Acetone, Hexane, MeCl2 or MeOH ext. of dried leaf Microdilution assay (C. albicans)—MIC for drugs: >2.5, 0.16, 0.64 or >2.5 mg/mL, respectively Active [73]
Microdilution assay (C. neoformans)—MIC for drugs: 0.32, 0.32, 0.16 or 0.32 mg/mL, respectively Active [73]
Microdilution assay (A. fumigates)—MIC for drugs: >2.5, 0.16 mg/mL, respectively Active [73]
Microdilution assay (S. schenckii)—MIC for drugs: 0.64, 0.64, 0.64 or 0.32 mg/mL, respectively Active [73]
Microdilution assay (M. canis)—MIC for drugs: 0.08, 0.32, 0.32 or 0.16 mg/mL, respectively Active [73]
C. celastroides Welw ex Laws subsp. celastroides Acetone, Hexane, MeCl2 or MeOH ext. of dried leaf Microdilution assay (C. albicans)—MIC for drugs: 0.16, 0.64, 0.32, 0.64 mg/mL, respectively Active [73]
Microdilution assay (C. neoformans)—MIC for drugs: 0.16, 0.16, 0.08 or 0.32 mg/mL, respectively Active [73]
Microdilution assay (A. fumigates)—MIC for drugs: 0.64, >2.5, 1.25 or 0.64 mg/mL, respectively Active [73]
Microdilution assay (S. schenckii)—MIC for drugs: 0.32, 0.32, 0.16 or 0.16 mg/mL, respectively Active [73]
Microdilution assay (M. canis)—MIC for drugs: 0.32, 0.64, 0.64 or 0.08 mg/mL, respectively Active [73]
C. celastroides Welw ex Laws subsp. orientale Acetone, Hexane, MeCl2 or MeOH ext. of dried leaf Microdilution assay (C. albicans)—MIC for drugs: 0.16, 0.32, 0.16 or 0.32 mg/mL, respectively Active [73]
Microdilution assay (C. neoformans)—MIC for drugs: 0.08, 0.32, 0.08 or 0.16 mg/mL, respectively Active [73]
Microdilution assay (A. fumigates)—MIC for drugs: 0.32, 2.5, 2.5 or 2.5 mg/mL, respectively Active [73]
Microdilution assay (S. schenckii)—MIC for drugs: 0.08, 0.16, 0.16 or 0.16 mg/mL, respectively Active [73]
Microdilution assay (M. canis)—MIC for drugs: 0.04, 0.32, 0.32 or 0.08 mg/mL, respectively Active [73]
C. collinum Fresen. subsp. suluense Okafor MeOH ext. of dried root Agar plate diffusion method-(C. albicans or A. niger)—Concentraton for drug: 1.0 mg/mL Active [57]
MeOH, EtOH or MeOH-H2O ext. of dried air parts Agar plate with diameters inhibition zones (C. albicans or A. niger)—Concentraton for drugs: 5 mg/mL with inhibition zone of 10 or 14 mm, respectively Active [57]
Agar plate with diameters inhibition zones (C. albicans or A. niger)—Concentraton for drugs: 1 mg/mL Inactive [57]
Acetone, Hexane, MeCl2 or MeOH ext. of dried leaf Microdilution assay (C. albicans)—MIC for drugs: 0.08, 2.5, 0.08 or 0.16 mg/mL, respectively Active [73]
Microdilution assay (C. neoformans)—MIC for drugs: 0.16, 2.5, 0.08 or 0.08 mg/mL, respectively Active [73]
Microdilution assay (A. fumigates)—MIC for all drugs: 2.5 mg/mL Active [73]
Microdilution assay (S. schenckii)—MIC for drugs: 0.16, 2.5, 0.16 or 0.32 mg/mL, respectively Active [73]
Microdilution assay (M. canis)—MIC for drugs: 0.64, 1.25, 0.64 or 0.32 mg/mL, respectively Active [73]
C. collinum Fresen. ssp taborense Acetone, Hexane, MeCl2 or MeOH ext. of dried leaf Microdilution assay (C. albicans)—MIC for all drugs: 0.64 mg/mL Active [73]
Microdilution assay (C. neoformans)—MIC for drugs: 0.08, 0.16, 0.32 or 0.32 mg/mL, respectively Active [73]
Microdilution assay (A. fumigates)—MIC for drugs: 0.64, 2.5, 2.5 or 2.5 mg/mL, respectively Active [73]
Microdilution assay (S. schenckii)—MIC for drugs: 0.64, 0.32, 0.32 or 0.64 mg/mL, respectively Active [73]
Microdilution assay (M. canis)—MIC for drugs: 0.32, 1.25, 0.64 or 0.16 mg/mL, respectively Active [73]
C. comosum G. Don. Hot H2O ext. of dried root Agar plate diffusion method (Saccharomyces cerevisiae or A. niger)—Concentration not cited Inactive [52]
C. edwardsii Exell Acetone, Hexane, MeCl2 or MeOH ext. of dried leaf Microdilution assay (C. albicans)—MIC for drugs: 0.32, 1.25, 1.25 or 0.64 mg/mL, respectively Active [73]
Microdilution assay (C. neoformans)—MIC for drugs: 0.04, 0.32, 0.32 or 0.16 mg/mL, respectively Active [73]
Microdilution assay (A. fumigates)- MIC for drugs: 2.5, 2.5, 2.5 or 2.5 mg/mL, respectively Active [73]
Microdilution assay (S. schenckii)—MIC for drugs: 0.04, 0.08, 0.08 or 0.04 mg/mL, respectively Active [73]
Microdilution assay (M. canis)—MIC for drugs: 0.04, 0.02, 0.04 or 0.04 mg/mL, respectively Active [73]
C. erythrophyllum (Burch.) Sond. Acetone, Hexane, MeCl2 or MeOH ext. of dried leaf Microdilution assay (C. albicans)—MIC for drugs: >2.5, 0.64, 0.64 or 2.5 mg/mL, respectively Active [73]
Microdilution assay (C. neoformans)—MIC for drugs: 2.5, 0.64, 0.32 or 0.64 mg/mL, respectively Active [73]
Microdilution assay (A. fumigates)—MIC for drugs: 2.5, >2.5, >2.5 or 2.5 mg/mL, respectively Active [73]
Microdilution assay (S. schenckii)—MIC for drugs: >2.5, 0.32, 0.32 or 1.25 mg/mL, respectively Active [73]
Microdilution assay (M. canis)—MIC for drugs: 0.02, 1.25, 0.32 or 0.16 mg/mL, respectively Active [73]
C. glutinosum Perrot. ex DC EtOH/H2O (1:1) ext. of dried leaf Microdilution assay (C. albicans, Epidermophyton. floccosum, M. gypseum, Tricophyton mentagrophytes or Tricophyton rubrum)—MIC for drug: >4.0, 4.0, 1.0, 1.0 or 1.0 mg/mL, respectively Active [72]
C. hereroense Schinz Acetone, Hexane, MeCl2 or MeOH ext. of dried leaf Microdilution assay (C. albicans)—MIC for drugs: 0.32, 0.32, 2.5 or 0.04, respectively Active [73]
Microdilution assay (C. neoformans)—MIC for drugs: 0.16, 0.08, 0.32 or 0.08 mg/mL, respectively Active [73]
Microdilution assay (A. fumigates)—MIC for drugs: 2.5, 2.5, 2.5 or 1.25 mg/mL, respectively Active [73]
Microdilution assay (S. schenckii)—MIC for drugs: 0.16, 0.16, 0.32 or 0.16 mg/mL, respectively Active [73]
Microdilution assay (M. canis)—MIC for drugs: 0.04, 0.02, 0.02 or 0.04 mg/mL, respectively Active [73]
C. hispidum Laws. EtOH-H2O (1:1) ext. of dried leaf Microdilution assay (C. albicans, E. floccosum, M. gypseum, T. mentagrophytes or T. rubrum)—MIC for drug: >4.0, >4.0, >4.0, 4.0 or 4.0 mg/mL, respectively Active [72]
C. imberbe Wawra Acetone, Hexane, MeCl2 or MeOH ext. of dried leaf Microdilution assay (C. albicans)—MIC for drugs: 2.5, 0.16, 0.16 or >2.5 mg/mL, respectively Active [73]
Microdilution assay (C. neoformans)—MIC for drugs: 0.16, 0.16, 0.32 or 0.32 mg/mL, respectively Active [73]
Microdilution assay (A. fumigates)—MIC for drugs: 2.5 mg/mL, respectively Active [73]
Microdilution assay (S. schenckii)—MIC for drugs: 2.5, >2.5, 0.32 or >2.5 mg/mL, respectively Active [73]
Microdilution assay (M. canis)—MIC for drugs: 0.32, 0.64, 0.16 or 0.32 mg/mL, respectively Active [73]
C. kraussii Hochst. Acetone, Hexane, MeCl2 or MeOH ext. of dried leaf Microdilution assay (C. albicans)—MIC for drugs: 2.5, 0.08, 0.32 or 1.25 mg/mL, respectively Active [73]
Microdilution assay (C. neoformans)—MIC for drugs: 0.64, 0.32, 0.16 or 0.32 mg/mL, respectively Active [73]
Microdilution assay (A. fumigates)—MIC for drugs: 0.64, 2.5, 2.5 or 0.16 mg/mL, respectively Active [73]
Microdilution assay (S. schenckii)—MIC for drugs: 0.64, 0.32, 0.32 or 0.64 mg/mL, respectively Active [73]
Microdilution assay (M. canis)—MIC for drugs: 0.32, 0.16, 0.64 or 0.04 mg/mL, respectively Active [73]
C. micranthum G. Don MeOH, EtOH or MeOH-H2O ext. of dried air parts Agar plate with diameters inhibition zones (C. albicans)—Concentraton for drugs: 5 mg/mL with inhibition zone of 11 mm Active [57]
Agar plate with diameters inhibition zones (C. albicans)—Concentraton for drugs: 1 mg/mL Inactive [57]
Agar plate with diameters inhibition zones (A. niger)—Concentraton for drugs: 1 or 5 mg/mL Inactive [57]
EtOH (95%) ext. of dried twigs Agar plate with diameters inhibition zones (A. niger)—Concentration for drug: 50 or 5 mg/mL Inactive [49]
Hot H2O ext. of dried root Agar plate diffusion method (A. niger)—Concentration not cited Inactive [52]
EtOH (95%) ext. of sun dried twig Agar plate diffusion method (A. niger)—Concentration for drug: 50.0 mg/mL Inactive [54]
EtOH (100%) ext. of dried leaf Agar plate diffusion method (A. niger)—Concentration for drug: 1.0 mg/mL Inactive [57]
C. microphyllum Klotzsch Acetone, Hexane, MeCl2 or MeOH ext. of dried leaf Microdilution assay (C. albicans)—MIC for all drugs: 2.5 mg/mL Active [73]
Microdilution assay (C. neoformans)—MIC for drugs: 0.16, 0.64, 0.08 or 0.16 mg/mL, respectively Active [73]
Microdilution assay ( A. fumigates)—MIC for all drugs: 2.5 mg/mL Active [73]
Microdilution assay (S. schenckii)—MIC for drugs: 0.64, 0.64, 0.32 or 0.32 mg/mL, respectively Active [73]
C. moggi Exell Acetone, Hexane, MeCl2 or MeOH ext. of dried leaf Microdilution assay (C. albicans)—MIC for drugs: 0.64, 1.25, 1.25 or 0.02 mg/mL, respectively Active [73]
Microdilution assay (C. neoformans)—MIC for drugs: 0.08, 0.32, 0.32 or 0.04 mg/mL, respectively Active [73]
Microdilution assay (A. fumigates)—MIC for all drugs: 2.5 mg/mL Active [73]
Microdilution assay (S. schenckii)—MIC for drugs: 0.02, 0.16, 0.08 or 0.02 mg/mL, respectively Active [73]
Microdilution assay (M. canis)—MIC for drugs: 0.04, 0.08, 0.04 or 0.02 mg/mL, respectively Active [73]
C. molle R.Br. ex G. Don. MeOH ext. of dried bark Microdilution assay (C. albicans)—MIC for drug: 5.0 mg/mL Active [129]
MeOH ext. of dried wood Agar plate diffusom method (C. albicans)—Concentration for drug: 5.0 mg/disc Inactive [129]
EtOH/H2O (1:1) ext. of dried leaf Microdilution assay (C. albicans, E. floccosum, M. gypseum, T. mentagrophytes or T. rubrum)—MIC for drug: > 4.0, 0.5, 0.25, 0.25 or 0.5 mg/mL, respectively Active [72]
MeOH ext. of dried root Macro-broth tube dilution method (C. albicans)—MIC for drug: 1 mg/mL Active [136]
H2O ext. of dried root Macro-broth tube dilution method (C. albicans)—MIC for drug: 6.50 mg/mL Active [136]
Acetone, Hexane, MeCl2 or MeOH ext. of dried leaf Microdilution assay (C. albicans)—MIC for drugs: 0.04, 1.25, 0.32 or 0.32 mg/mL, respectively Active [73]
Microdilution assay (C. neoformans)—MIC for drugs: 0.04, 1.25, 0.16 or 0.08 mg/mL, respectively Active [73]
Microdilution assay (A. fumigates)—MIC for drugs: 1.25, 2.5, 2.5 or 2.5 mg/mL, respectively Active [73]
Microdilution assay (S. schenckii)—MIC for drugs: 0.08, 0.32, 0.32 or 0.08 mg/mL, respectively Active [73]
Microdilution assay (M. canis)—MIC for drugs: 0.02, 0.02, 0.04 or 0.02 mg/mL, respectively Active [73]
C. mossambicense (Klotzsch) Engl. Acetone, Hexane, MeCl2 or MeOH ext. of dried leaf Microdilution assay (C. albicans)—MIC for drugs: 1.25, 2.5, 2.5 or 1.25 mg/mL, respectively Active [73]
Microdilution assay (C. neoformans)—MIC for drugs: 1.25, 1.25, 0.64 or 0.64 mg/mL, respectively Active [73]
Microdilution assay (A. fumigates)—MIC for all drugs: 2.5 mg/mL Active [73]
Microdilution assay (S. schenckii)—MIC for drugs: 0.64, 0.16, 0.16 or 0.16 mg/mL, respectively Active [73]
Microdilution assay (M. canis)—MIC for drugs: 0.08, 0.04, 0.02 or 0.32 mg/mL, respectively Active [73]
C. nelsonii Dümmer Acetone, Hexane, MeCl2 or MeOH ext. of dried leaf Microdilution assay (C. albicans)—MIC for drugs: 0.04, 0.16, 0.32 or 0.16 mg/mL, respectively Active [73]
Microdilution assay (C. neoformans)—MIC for drugs: 0.16, 0.32, 0.32 or 0.16 mg/mL, respectively Active [73]
Microdilution assay (A. fumigates)—MIC for drugs: 0.64, 2.5, 0.64 or 0.64 mg/mL, respectively Active [73]
Microdilution assay (S. schenckii )—MIC for drugs: 0.08, 0.32, 0.16 or 0.16 mg/mL, respectively Active [73]
Microdilution assay (M. canis)—MIC for all drugs: 0.02 mg/mL Active [73]
C. nigricans Lepr. EtOH/H2O (1:1) ext. of dried leaf Microdilution assay (C. albicans, E. floccosum, M. gypseum, T. mentagrophytes or T. rubrum)—MIC for drug: >4.0, 1.0, 1.0, 1.0 or 1.0 mg/mL, respectively Active [72]
EtOH/H2O (1:1) ext. of dried entire root Microdilution assay (C. albicans, E. floccosum, M. gypseum, T. mentagrophytes or T. rubrum)—MIC for drug: >4.0, 0.25, 0.5, 0.25 or 0.5 mg/mL, respectively Active [72]
C. padoides Engl. & Diels Acetone, Hexane, MeCl2 or MeOH ext. of dried leaf Microdilution assay (C. albicans)—MIC for drugs: 0.16, 0.32, 0.32 or >2.5 mg/mL, respectively Active [73]
Microdilution assay (C. neoformans)—MIC for drugs: 0.32, 0.64, 0.32 or 0.32 mg/mL, respectively Active [73]
Microdilution assay (A. fumigates)—MIC for drugs: 0.32, 2.5, 2.5 or 0.32 mg/mL, respectively Active [73]
Microdilution assay (S. schenckii)—MIC for drugs: 0.32, >2.5, >2.5 or 0.64 mg/mL, respectively Active [73]
Microdilution assay (M. canis)—MIC for drugs: 0.08, 0.64, 0.16 or 0.08 mg/mL, respectively Active [73]
C. paniculatum Vent. Acid-EtOH or H2O ext. of dried leaf Agar plate diffusion method (C. albicans)—Concentration for drug: 0.20 mL/disc (1,000 µg/mL) Active [132]
MeOH or H2O ext. of dried root Macro-broth tube dilution method (C. albicans)—MIC for drugs: 5.55 or 14.44 mg/mL, respectively Active [136]
Acetone, Hexane, MeCl2 or MeOH ext. of dried leaf Microdilution assay (C. albicans)—MIC for all drugs: 2.5 mg/mL Active [73]
Microdilution assay (C. neoformans)—MIC for drugs: 0.32, 1.25, 0.16 or 0.16 mg/mL, respectively Active [73]
Microdilution assay (A. fumigates)—MIC for all drugs: 2.5 mg/mL Active [73]
Microdilution assay (S. schenckii)—MIC for drugs: 0.32, 0.32, 0.04 or 0.04 mg/mL, respectively Active [73]
Microdilution assay (M. canis)—MIC for drugs: 0.02, 0.02, 0.02 or 0.08 mg/mL, respectively Active [73]
C. petrophilum Retief Acetone, Hexane, MeCl2 or MeOH ext. of dried leaf Microdilution assay (C. albicans)—MIC for drugs: 0.04, 2.5, 2.5 or 0.04 mg/mL, respectively Active [73]
Microdilution assay (C. neoformans)—MIC for drugs: 0.02, 0.32, 2.5 or 0.02 mg/mL, respectively Active [73]
Microdilution assay (A. fumigates)—MIC for all drugs: 2.5 mg/mL Active [73]
Microdilution assay (S. schenckii)—MIC for drugs: 0.08, 0.32, 0.32 or 0.04 mg/mL, respectively Active [73]
Microdilution assay (M. canis)—MIC for all drugs: 0.02, 0.04, 0.04 or 0.02 mg/mL, respectively Active [73]
C. woodii Dümmer Acetone, Hexane, MeCl2 or MeOH ext. of dried leaf Microdilution assay (C. albicans)—MIC for drugs: 0.16, 0.08, 0.16 or 0.32 mg/mL, respectively Active [73]
Microdilution assay (C. neoformans)—MIC for drugs: 0.32, 0.16, 0.16 or 2.5 mg/mL, respectively Active [73]
Microdilution assay (A. fumigates)—MIC for drugs: 1.25, 2.5, 1.25 or 2.5 mg/mL, respectively Active [73]
Microdilution assay (S. schenckii)—MIC for drugs: 0.32, 0.32, 0.32 or 1.25 mg/mL, respectively Active [73]
Microdilution assay (M. canis)—MIC for all drugs: 0.32 mg/mL Active [73]
C. zeyheri Sond. MeOH ext. of dried entire plant Agar plate diffusion method (C. albicans or T. mentagrophytes)—Concentration for drug: 0.03 mg/mL Active [137]
Acetone, Hexane, MeCl2 or MeOH ext. of dried leaf Microdilution assay (C. albicans)—MIC for drugs: 0.16, 2.5, 1.25 or 0.16 mg/mL, respectively Active [73]
Microdilution assay (C. neoformans)—MIC for all drugs: 0.32 mg/mL Active [73]
Microdilution assay (A. fumigates)—MIC for all drugs: 2.5 mg/mL Active [73]
Microdilution assay (S. schenckii)—MIC for drugs: 0.02, 0.08, 0.04 or 0.08 mg/mL, respectively Active [73]
Microdilution assay (M. canis)—MIC for drugs: 0.02, 0.02, 0.02 or 0.04 mg/mL, respectively Active [73]
Hypoglycemic activity
C. decandrum Roxb. (DC) EtOH (70%) ext. of dried leaf Streptozotocin-induced diabetic in rat—Dose for drug: 0.75 g/kg (p.o.) Active [138]
C. micranthum G. Don H2O ext. of leaves Induction of Diabetes mellitus Type 1 and 2 by alloxan in rats—Doses for drug: 100, 200 or 400 mg/kg (p.o.) Active [63]
Antiinflammatory activity
C. collinum Fresen. H2O ext. of dried stem bark 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced ear inflammation in mice—Dose for drug: 0.5 mg/ear Active [139]
Carrageenan-induced pedal edema in mice—Dose for drug: 100.0 mg/kg (p.o.) Active [139]
C. dolichopetalum Gils ex Engl. MeOH ext. of dried root Carrageenan-induced paw edema in mice—Doses for drug: 200, 400 or 600.0 mg/kg (p.o.) Active [96]
CHCl3 ext. of dried root Croton oil-induced ear edema in mice—Doses for drug: 0.25, 0.5 or 1.0 mg/ear Active [96]
C. apiculatum Sond. subsp. apiculatum H2O, Acetone or AcOEt ext. of dried leaf In vitro-Cyclooxygenase-1 (COX-1) inhibition by radioactivity bioassay—Concentration not cited Active [112]
C. bracteosum (Hochst.) Brandis ex Engl. H2O, Acetone or AcOEt ext. of dried leaf In vitro-Cyclooxygenase-1 (COX-1) inhibition by radioactivity bioassay—Concentration not cited Active [112]
C. celastroides Welw ex Laws subsp. celastroides H2O, Acetone or AcOEt ext. of dried leaf In vitro-Cyclooxygenase-1 (COX-1) inhibition by radioactivity bioassay—Concentration not cited Active [112]
C. collinum Fresen. subsp. suluense (Engl. & Diels) Okafor H2O, Acetone or AcOEt ext. of dried leaf In vitro-Cyclooxygenase-1 (COX-1) inhibition by radioactivity bioassay—Concentration not cited Active [112]
C. duarteanum Cambess. EtOH ext. of dried leaf Carrageenan or arachidonic acid-induced hind paw edema in mice—Doses for drug: 200 or 400 mg/kg (i.p.) Active [140]
C. edwardsii Exell H2O, Acetone or AcOEt ext. of dried leaf In vitro-Cyclooxygenase-1 (COX-1) inhibition by radioactivity bioassay—Concentration not cited Active [112]
C. erythrophyllum (Burch.) Sond. H2O, Acetone or AcOEt ext. of dried leaf In vitro-Cyclooxygenase-1 (COX-1) inhibition by radioactivity bioassay—Concentration not cited Active [112]
C. hartmannianum Schweinf. MeCl2 or EtOH ext. of dried leaf In vitro-Cyclooxygenase-1 (COX-1) inhibition by radioactivity bioassay—Concentration for all drugs: 250 μg/mL Active [126]
AcOEt ext. of dried leaf In vitro-Cyclooxygenase-1 (COX-1) inhibition by radioactivity bioassay—Concentration for drug: 250 μg/mL Inactive [126]
MeCl2 or AcOEt ext. of dried bark In vitro-Cyclooxygenase-1 (COX-1) inhibition by radioactivity bioassay—Concentration for all drugs: 250 μg/mL Inactive [126]
EtOH ext. of dried bark In vitro-Cyclooxygenase-1 (COX-1) inhibition by radioactivity bioassay—Concentration for drug: 250 μg/mL Active [126]
MeCl2, AcOEt or EtOH ext. of dried root In vitro-Cyclooxygenase-1 (COX-1) inhibition by radioactivity bioassay—Concentration for all drugs: 250 μg/mL Inactive [126]
C. hereroense Schinz H2O, Acetone or AcOEt ext. of dried leaf In vitro-Cyclooxygenase-1 (COX-1) inhibition by radioactivity bioassay—Concentration not cited Active [112]
C. imberbe Wawra H2O, Acetone or AcOEt ext. of dried leaf In vitro-Cyclooxygenase-1 (COX-1) inhibition by radioactivity bioassay—Concentration not cited Active [112]
C. kraussii Hochst. H2O, Acetone or AcOEt ext. of dried leaf In vitro-Cyclooxygenase-1 (COX-1) inhibition by radioactivity bioassay—Concentration not cited Active [112]
C. microphyllum Klotzsch H2O, Acetone or AcOEt ext. of dried leaf In vitro-Cyclooxygenase-1 (COX-1) inhibition by radioactivity bioassay—Concentration not cited Active [112]
C. mkuzense Carr & Retief H2O, Acetone or AcOEt ext. of dried leaf In vitro-Cyclooxygenase-1 (COX-1) inhibition by radioactivity bioassay—Concentration not cited Active [112]
C. moggii Exell H2O ext. of dried leaf In vitro-Cyclooxygenase-1 (COX-1) inhibition by radioactivity bioassay—Concentration not cited Inactive [112]
Acetone or AcOEt ext. of dried leaf In vitro-Cyclooxygenase-1 (COX-1) inhibition by radioactivity bioassay—Concentration not cited Active [112]
C. molle R. Br. Ex G. Don H2O, Acetone or AcOEt ext. of dried leaf In vitro-Cyclooxygenase-1 (COX-1) inhibition by radioactivity bioassay—Concentration not cited Active [112]
C. mossambicense (Klotzsch) Engl. H2O, Acetone or AcOEt ext. of dried leaf In vitro-Cyclooxygenase-1 (COX-1) inhibition by radioactivity bioassay—Concentration not cited Active [112]
C. nelsonii Dümmer H2O, Acetone or AcOEt ext. of dried leaf In vitro-Cyclooxygenase-1 (COX-1) inhibition by radioactivity bioassay—Concentration not cited Active [112]
C. padoides Engl. & Diels H2O, Acetone or AcOEt ext. of dried leaf In vitro-Cyclooxygenase-1 (COX-1) inhibition by radioactivity bioassay—Concentration not cited Active [112]
C. paniculatum Vent. H2O, Acetone or AcOEt ext. of dried leaf In vitro-Cyclooxygenase-1 (COX-1) inhibition by radioactivity bioassay—Concentration not cited Active [112]
C. petrophilum Retief H2O, Acetone or AcOEt ext. of dried leaf In vitro-Cyclooxygenase-1 (COX-1) inhibition by radioactivity bioassay—Concentration not cited Active [112]
C. woodii Dümmer H2O ext. of dried leaf In vitro-Cyclooxygenase-1 (COX-1) inhibition by radioactivity bioassay—Concentration not cited Inactive [112]
Acetone or AcOEt ext. of dried leaf In vitro-Cyclooxygenase-1 (COX-1) inhibition by radioactivity bioassay—Concentration not cited Active [112]
C. hartmannianum Schweinf. MeCl2, EtOAc or EtOH ext. of dried leaf In vitro-Cyclooxygenase-2 (COX-2) inhibition by radioactivity bioassay—Concentration for all drugs: 250 μg/mL Active [126]
EtOAc or EtOH ext. of dried bark In vitro-Cyclooxygenase-2 (COX-2) inhibition by radioactivity bioassay—Concentration for all drugs: 250 μg/mL Inactive [126]
MeCl2, EtOAc or EtOH ext. of dried root In vitro-Cyclooxygenase-2 (COX-2) inhibition by radioactivity bioassay—Concentration for all drugs: 250 μg/mL Inactive [126]
C. micranthum G. Don. Hot H2O of dried aerial parts Radioactivity assays of PGs isolated of stomach in rat—Concentration for drug: 100.0 µL/mL Inactive [141]
H2O ext. of dried leaf Carrageenan-induced paw oedema or Cotton pellet granuloma formation in rats—Doses for drug: 50 or 100 mg/kg (p.o.) Active [142]
Acetic acid-induced vascular permeability in mice—Doses for drug: 50 or 100 mg/kg (p.o.) Active [142]
Antinociceptive activity
C. duarteanum Cambess. EtOH ext. of dried leaf Acid-induced writhing, formalin, and hot-plate nociception tests in mice—Doses for drug: 100, 200, or 400 mg/kg (i.p.) Active [140]
C. leprosum Mart. EtOH ext. of dried flowers Formalin induced nociception in mice—Doses for drug: 100 and 300 mg/kg (p.o) Active [7]
Abdominal contortion by acetic acid in mice—Doses for drug: 30, 100, 300, 1.000 mg/kg (p.o.) Active [7]
Capsaicin-induced nociception in mice—Doses for drug: 30, 100, 300, 1.000 mg/kg (p.o.) Active [7]
Glutamate induced nociception in mice—Doses for drug: 10, 30, 100, 300 mg/kg (p.o.) Active [7]
Hot plate test in mice—Doses for drug: 10, 30, 100, 300 mg/kg (p.o.) Active [7]
EtOH (70%) ext. of dried stem bark Tail immersion test and Formalin-induced pain in mice—Doses for drug: 25.0 mg/kg (i.p.) or 500.0 mg/kg (p.o.) Active [143]
Antioxidant activity
C. decandrum Roxb. (DC) EtOH (70%) ext. of dried leaf Thiobarbituric acid-reactive substance or ferrous ion oxidation xylenol orange in rats—Dose for drug: 0.75 g/kg (p.o.) Active [138]
C. duarteanum Cambess. EtOH ext. of dried leaf Thiobarbituric acid-reactive substance, hydroxyl radical-scavenging, or scavenging activity of nitric oxide assays. Active [140]
Anti-tumour activity
C. caffrum (Eckl. and Zeyh.) Kuntze CHCl3, CCl4 or CH2Cl2 fractions of dried fruit, leaf, stem or twig In vitro-Cell culture (immature astrocytoma 224c glioma cell)—Concentration for drugs: 1.0–100 μg/mL Active [144]
CCl4 or CH2Cl2 fraction of dried fruit, leaf, stem or twig In vitro-P388 lymphocytic leukemia cell growth inhibition (ED50 for drugs: 1.5 or 0.23 µg/mL, respectively) Active [144]
Murine P-388 lymphocytic leukemia cell growth inhibition—Doses for drugs (i.p.): 100 or 50 mg/kg, respectively Active [144]
MeCl2 ext. of dried root bark Murine P-388 lymphocytic leukemia cell growth inhibition—Dose not cited (i.p.). Active [145]
C. collinum Fresen. MeOH, EtOH or MeOH-H2O ext. of dried air parts In vitro-Cell culture (Squamous carcinoma KB, Melanoma SK—MEL28, lung carcinoma A549, or mamma carcinoma MDA—MB231)-IC50 for all drugs: 20.0 μg/mL Active [57]
Antitussive activity
C. glutinosum Perrot. ex DC H2O ext. of dried leaf Guinea pig—Dose for drug: 1.0 mg/kg (p.o.) Active [146]
Antiviral activity
C. glutinosum Perrot. ex DC Decoction of leaf In vitro-Cell culture (hepatitis B virus antigen HBsAg-IC50 for drug:100.0–500 ng/mL Active [147]
C. grandiflorum G. Don EtOH (80%) ext In vitro-Cell culture (plaque-inhibition in cells infected with virus-Adenovirus)—Concentration not cited Inactive [148]
EtOH (80%) ext In vitro-Cell culture (plaque-inhibition in cells infected with virus Herpes type 1)—Concentration for drug: Inactive [148]
In vitro-Cell culture (plaque-inhibition in cells infected with virus measles)—Concentration not cited Inactive [148]
In vitro-Cell culture (plaque-inhibition in cells infected with virus Poliovirus I)—Concentration not cited Inactive [148]
EtOH (80%) ext In vitro-Cell culture (plaque-inhibition in cells infected with virus Coxsackie B2)—Concentration for drug: Inactive [148]
In vitro-Cell culture (plaque-inhibition in cells infected with virus Semlicki forest)—Concentration not cited Inactive [148]
C. micranthum G. Don. MeOH ext. of dried leaf In vitro-Cell culture: African green monkey cells infected with virus Herpes simplex 1 or H. simplex 2—Concentration for drug: 7.5 μg/mL Active [58]
C. paniculatum Vent. MeOH ext. of dried leaf In vitro-Cell culture: MT-4 cells infected with virus human immunodeficiency type 1 (HIV 1)—IC50 for drug: 5.2 μg/mL Active [149]
In vitro-Cell culture: MT-4 cells infected with virus HIV 2 (rod)—Concentration for drug: >24.6 μg/mL Inactive [149]
EtOH (80%) ext. of dried leaf In vitro-Cell culture: MT-4 cells infected with virus HIV 1 or HIV 2 (ROD)—Concentration for drug: >23.5 μg/mL Inactive [149]
Pet ether ext. of dried leaf In vitro-Cell culture: MT-4 cells infected with virus HIV 1 or HIV 2 (ROD)—Concentration for drug: >118 μg/mL Inactive [149]
MeCl2 ext. of dried leaf In vitro-Cell culture: MT-4 cells infected with virus HIV 1 or HIV 2 (ROD)—Concentration for drug: >44.7 μg/mL Inactive [149]
Acetone ext. of dried leaf In vitro-Cell culture: MT-4 cells infected with virus HIV 1 or HIV 2 (ROD)-IC50 for drug: 15.0 or 3.0 μg/mL, respectively Active [149]
C. quadrangulare Kurz. EtOH (95%) or H2O ext. of dried leaf In vitro-HIV 1 integrase inhibition by cell culture with virus HIV 1)-IC50 for drugs: 2.5 or 2.9 μg/mL, respectively Active [103]
C. molle R. Br. Ex G. Don H2O or MeOH ext. of roots In vitro-RNA-dependent-DNA polymerase (RDDP) activity of HIV1 reverse transcriptase-IC50 for drugs: 37or 9.7 μg/mL, respectively Active [80]
Immunostimulant activity
C. micranthum G. Don Suspension of powder leaf Rate of clearance of colloidal carbon by mice—Dose for drug: 100.0 mg/kg (i.v.) Active [62]
Cardiovascular activity
C. hypopilinum Diels MeOH ext. of seed Depressant cardiac in rabbit - Dose not cited Active [150]
C. nigricans Lepr. MeOH ext. of seed Rabbit-heart- Dose not cited Active [150]
C. sokodense Engl. MeOH ext. of seed Rabbit-heart- Dose not cited Active [150]
C. verticillatum Engl. & Diels MeOH ext. of seed Rabbit-heart- Dose not cited Active [150]
C. racemosum P. Beauv Hot H2O ext. of dried leaf Blood pressure blocked by DHE in cat—Dose for drug: 0.5 mL/kg (i.v.) Inactive [151]
C. hypopilium Diels MeOH ext Hypotensive in cat—Dose for drug: 250.0 mg/kg (i.v.) Active [150]
C. nigricans Lepr. MeOH ext. of seed Hypotensive in cat—Dose for drug: 250.0 mg/kg (i.v.) Active [150]
C. ovalifolium var.cooperi EtOH/H2O (1:1) ext. of aerial parts Cat—Dose for drug: 50.0 mg/kg (i.v.) Active [152]
C. sokodense Engl. MeOH ext. of seed Hypotensive in cat—Dose for drug: 250.0 mg/kg (i.v.) Active [150]
C. verticillatum Engl. & Diels MeOH ext. of seed Hypotensive in cat—Dose for drug: 250.0 mg/kg (i.v.) Active [150]
CNS activity
C. hypopilium Diels MeOH ext. of seed Depressant CSN im mice—Dose for drug:0.5 mg/kg (i.p.) Active [150]
C. nigricans Lepr. MeOH ext. of seed Depressant CSN im mice—Dose for drug: 0.5 mg/kg (i.p.) Active [150]
C. paniculatum Vent. MeOH ext. of seed Stimulate CSN im mice—Dose for drug: 0.5 mg/kg (i.p.) Active [150]
C. sokodense Engl. MeOH ext. of seed Depressant CSN im mice—Dose for drug: 0.5 mg/kg (i.p.) Active [150]
C. verticillatum Engl. & Diels MeOH ext. of seed Depressant CSN im mice—Dose for drug: 0.5 mg/kg (i.p.) Active [150]
Toxicity studies
Mutagenicity
C. erythrophyllum (Burch.) Sond. H2O ext. of dried root In vitro-Agar plate with S. typhimurium TA97a and TA98-Concent. for drug: 100.0–20.0 μg/disc Inactive [90]
In vitro-Agar plate with S. typhimurium TA100 and TA102—Concentration for drug: 40.0, 70.0, 80.0, 90.0, 100.0 μg/disc Active [90]
In vitro-Spermatocytes drosophila sex-linked recessive lethal concentration 50% (LD50)—Dose for drug: 1.0 mg/mL Active [86]
Cytotoxicity
C. apiculatum Sond. subsp apiculatum MeOH ext. of dried leaf In vitro-Cell culture (T24 bladder or MCF7 breast cancer)—Concentration of drug: 25 µg/mL Active [15]
MeOH ext. of dried root In vitro-Cell culture (T24 bladder, HeLa cervical or MCF7 breast cancer)—Concentration of drug: 25 µg/mL Active [15]
C. aculeatum Vent. MeCl2, MeOH, H2O ext. of dried leaf In vitro-Cell culture Concentration for drugs: 500.0 μg/mL or 500.0 ppm Inactive [122]
H2O ext. of dried root In vitro-Cell culture (SW480 colon cancer cells)—Concentration for drug: 500.0 ppm Inactive [122]
MeCl2 ext. of dried root In vitro-Cell culture (CO115 colon cancer cells)—Concentration for drug: 500.0 μg/mL Inactive [122]
MeOH or H2O ext. of dried root In vitro-Cell culture (CO115 colon cancer cells)—Concentration for drugs: 500.0 ppm Inactive [122]
MeCl2 ext. of dried stem In vitro-Cell culture (SW480 colon cancer cells or CO115 colon cancer cells)—Concentration for drug: 500.0 μg/mL Inactive [122]
MeOH or H2O ext. of dried stem In vitro-Cell culture (SW480 colon cancer cells or CO115 colon cancer cells)—Concentration for drugs: 500.0 ppm Inactive [122]
C. collinum Fresen. MeOH ext. of dried leaf Cell culture (T24 bladder or MCF7 breast cancer)—Concentration for drug: 25 µg/mL Active [15]
MeOH ext. of dried root Cell culture (T24 bladder, HELA cervical or MCF7 breast cancer)—Concentration for drug: 25 µg/mL Active [15]
C. comosum G. Don. MeOH, MeOH/H2O (50:50) or MeCl2 ext. of dried leaves In vitro-Cell culture (THP1human monocytes)-IC50 for drugs: 63.1, >100 or 98.3 μg/mL, respectively Active [116]
C. cuspidatum Planch. ex Benth. MeOH, MeOH/H2O (50:50) or MeCl2 ext. of stem barks In vitro-Cell culture (THP1 human monocytes)-IC50 for drugs: >100, >100 or 25.3 μg/mL, respectively Active [116]
C. duarteanum Cambess. EtOH (95%) ext. of dried leaf In vitro-Cell culture (KB cells)—Concentration not cited Active [153]
EtOH (95%) ext. of dried root In vitro-Cell culture (KB cells)—Concentration not cited Active [153]
EtOH (95%) ext. of dried stem In vitro-Cell culture (KB cells)—Concentration not cited Active [153]
C. fragrans F. Hoffm. MeOH ext. of dried leaf or dried root Cell culture (T24 bladder, , HeLa cervical or MCF7 breast cancer)—Concentration for drugs: 25 µg/mL Active [15]
C. fruticosum (Loefl.) Stuntz EtOAc ext In vitro-Cell culture (CA-9KB)—ED50 for drug: 6.5 μg/mL Active [154]
H2O ext In vitro-Cell culture (CA-9KB)—ED50 for drug: 10.0 μg/mL Active [154]
Type ext. not stated In vitro-Cell culture (CA-9KB)—Dose for drug: >100 μg/mL Inactive [154]
Hexane ext. In vitro-Cell culture (CA-9KB)—ED50 for drug: 11.0 μg/mL Active [154]
C. hereroense Schinz MeOH ext. of dried stem bark Cell culture (T24 bladder, HeLa cervical or MCF7 breast cancer)—Concentration for drug: 25µg/mL Active [15]
C. micranthum G. Don MeOH ext. of dried leaf In vitro-Cell culture (human monocytes-THP1 cells)—Concengration for drug: >25.0 μg/mL Inactive [61]
MeOH ext. of dried leaf or dried root In vitro-Cell culture (T24 bladder, HeLa cervical or MCF7 breast cancer)—Concentration for drugs: 25 µg/mL Active [15]
C. nigricans Lepr. MeOH ext. of fresh leaf In vitro-Cell culture (U-373 MG human astrocytoma cells)—IC50 for drug: 41.0 μg/mL Active [155]
In vitro-Cell culture (HCT-15 colon human cells)—IC50 for drug: 41.0 μg/mL Active [155]
In vitro-Cell culture (A549 cancer cells)—IC50 for drug: 41.0 μg /mL Active [155]
In vitro-Cell culture (J82 human urothelial cells)—IC50 for drug: 41.0 μg/mL Active [155]
C. ovalifolium Roxb. var. cooperi EtOH-H2O (1:1) ext. of aerial parts In vitro-Cell culture (CA-9KB cells)—Dose for drug: >20.0 μg/mL Inactive [152]
C. padoides Engl. & Diels MeOH ext. of dried stem bark In vitro-Cell culture (T24 bladder, HeLa cervical or MCF7 breast cancer)—Concentration for drug: 25 µg/mL Active [15]
MeOH ext. of dried root In vitro-Cell culture (T24 bladder, HeLa cervical or MCF7 breast cancer)—Concentration for drug: 25 µg/mL Active [15]
C. psidioides Welw. MeOH ext. of dried stem bark In vitro-Cell culture (T24 bladder, HeLa cervical or MCF7 breast cancer)—Concentration for drug: 25 µg/mL Active [15]
C. zeyheri Sond. MeOH ext. of dried fruit In vitro-Cell culture (T24 bladder, HeLa cervical or MCF7 breast cancer)—Concentration for drug: 25 µg/mL Active [15]
MeOH ext. of dried root In vitro-Cell culture (T24 bladder, HeLa cervical or MCF7 breast cancer)—Concentration for drug: 25 µg/mL Active [15]
MeCl2 ext. of dried leaf In vitro-Cell culture (Renal TK10, Breast MCF7 or Melanoma UACC62 cancer)—IC50 for drug: 15.00, 28.21 or 10.33 mg/mL, respectively Active [156]
C. erythrophyllum (Burch) Sond MeOH ext. of dried wood In vitro-DNA damage assay-Cell culture Ycp (gal) or pRAD52 (glu)—IC50 for drug: 4.0 or 15 μg/mL, respectively Active [91]
In vitro-DNA damage assay-Cell culture pRAD52 (gal)—IC50 for drug: >100 μg/mL Inactive [91]
MeCl2 ext. of dried wood In vitro-DNA damage assay-Cell culture Ycp (gal), pRAD52 (gal), pRAD52 (glu), phTOP1 (gal) or phTOP1 (glu)—IC50 for drug: 2.0, 34.0, 31.0, 3.3 or 4.3 μg/mL, respectively Active [91]
In vitro-DNA damage by agar diffusion assay (RS188-WT erg6 or RS321-Rad52.erg6.top1)—IC50 for drug: 73.7 or 5.9 μg/mL, respectively Active [91]
In vitro-DNA damage by agar diffusion assay (RS322-Rad52.erg6)—IC50 for drug: >100 μg/mL Inactive [91]
EtOAc soluble fraction of dried wood In vitro-DNA damage assay-Cell culture Ycp (gal) or pRAD52 (glu)—IC50 for drug: 4.0 or 12 μg/mL, respectively Active [91]
In vitro-DNA damage assay-Cell culture pRAD52 (gal)—IC50 for drug: >100 μg/mL Inactive [91]
Brine shrimp lethality
C. aculeatum Vent. MeCl2, MeOH and H2O ext. of dried leaf, dried root bark or dried stem In vitro-Toxicity bioassay with Artemia salina L.—Concentration for all drugs: 500.0 μg/mL Inactive [122]
C. micranthum G. Don EtOH (100%) ext. of dried leaf In vitro-Toxicity bioassay with A. salina L.—LC50 for drug: 112.0 μg/mL Active [56]
CHCl3 or H2O ext. of dried leaf n vitro-Toxicity bioassay with A. salina L.—LC50 for drugs: 492.0 or 634.0 μg/mL, respectively Inactive [56]
EtOH (100%) ext. of dried bark In vitro-Toxicity bioassay with A. salina L.—LC50 for drug: 432.0 μg/mL Inactive [56]
C. zeyheri Sond MeOH ext. of dried root In vitro-Toxicity bioassay with A. salina L.—Concentration for all drugs: >0.1 mg/mL Inactive [157]
Molluscicidal
C. aculeatum Vent. MeCl2, MeOH or H2O ext. of dried leaf, dried root or dried stem In vitro-Toxicity bioassay with Biomphalaria glabrata—Concentration for all drugs: 400.0 ppm Inactive [122]
C. dolichopetalum Gils ex Engl. MeOH ext. of dried leaf In vitro-Toxicity bioassay with Bulinus globosus snail—Concentration for drug: 100.0 ppm Inactive [158]
C. ghasalense Engl. & Diels MeOH ext. of dried fruit or dried leaf In vitro-Toxicity bioassay with B. globosus snail—Concentration for all drugs: 100.0 ppm Inactive [158]
MeOH ext. of dried root or dried stem In vitro-Toxicity bioassay with B. globosus snail—Concentration for all drugs: 100.0 ppm Active [158]
MeOH ext. of dried stem In vitro-Toxicity bioassay with B. globosus snail—Concentration for drug: 100.0 ppm Active [159]
C. glutinosum Perrot. ex DC MeOH ext. of dried fruit, dried root or dried stem In vitro-Toxicity bioassay with B. globosus snail—Concentration for all drugs: 100.0 ppm Inactive [158]
C. leprosum Mart. EtOH (95%) or H2O ext. of dried stem bark In vitro-Toxicity bioassay with B. glabrata or B. straminea—Concentration for all drugs: 1,000 ppm Active [160]
C. micranthum G. Don MeOH ext. of dried leaf In vitro-Toxicity bioassay with B. globosus snail—Concentration for drug: 100.0 ppm Inactive [158]
C. molle R. Br. ex G. Don H2O ext. of dried leaf In vitro-Toxicity bioassay with Biomphalaria pfeifferi—Concentration for drug: 1:1,000 (v:v) Active [75]
Toxicity on mammals
C. decandrum Roxb. (DC) EtOH 50% ext. of entire plant Lethal dose 50% (LD50) in mice—LD50 for drug: 1.0 mg/kg (i.p.) Active [161]
C. dolichopetalum Gils ex Engl. EtOH (70%) ext. of dried root bark LD50 in rats—LD50 for drug: 246.0 mg/kg (i.p.) Active [97]
C. hypopilium MeOH ext. LD50 in mice—LD50 for drug: 2.3 mg/kg (i.v.) Active [150]
C. leprosum Mart. EtOH (70%) ext. of dried stem bark LD50 in mice—LD50 for drug: 4,722 mg/kg (p.o.) Active [143]
C. nanum Ham. ex D. Don. EtOH-H2O (1:1) ext. of dried entire plant LD50 in mice—LD50 for drug: 500.0 mg/kg (i.p.) Active [162]
C. nigricans Lepr. MeOH ext. of seed Lethal dose 50% (LD50) in mice—LD50 for drug: 580.0 mg/kg (i.v.) Active [150]
C. ovalifolium Roxb.var. cooperi EtOH-H2O (1:1) ext. of aerial parts Lethal dose 50% (LD50) in mice—LD50 for drug: 500.0 mg/kg (i.p) Active [152]
C. racemosum P. Beauv Hot H2O or EtOH (95%) ext. of dried leaf Lethal dose 50% (LD50) in mice—LD50 for drug: 17.78 mL/kg (i.p) Active [151]
C. sokodense Eng. MeOH ext. of seed Lethal dose 50% (LD50) in mice—LD50 for drug: 700.0 mg/kg (i.v.) Active [150]
C. verticillatum Engl. & Diels MeOH ext. of seed Lethal dose 50% (LD50) in mice—LD50 for drug: 800.0 mg/kg (i.v.) Active [150]
Antihepatotoxicity
C. dolichopetalum Gils ex Engl. EtOH (95%) ext. of fresh root bark Paracetamol-induced hepatotoxicity in rat—Dose for drug: 100.0 mg/kg (p.o.) Active [95]
C. quadrangulare Kurz. MeOH ext. of dried seed D-Galactosamine (D-GalN)/tumor necrosis factor-alpha(TNF-alpha)-induced hepatotoxicity in mice—IC50 for drug: 56.4 μg /mL Active [101]
MeOH/H2O (1:1) or H2O ext. of dried seed D-Galactosamine (D-GalN)/tumor necrosis factor-alpha(TNF-alpha)-induced hepatotoxicity in mice —Concentration for drug: 100.0 μg/mL Inactive [101]
H2O soluble fraction of dried seed D-Galactosamine (D-GalN)/tumor necrosis factor-alpha(TNF-alpha)-induced hepatotoxicity in mice —Concentration for drug: IC50 39.3 μg/mL Active [101]
MeOH soluble fraction of dried seed D-Galactosamine (D-GalN)/tumor necrosis factor-alpha(TNF-alpha)-induced hepatotoxicity in mice—Concentration for drug: 42.1 μg/mL Inactive [101]
Abortifacient
C. glutinosum Perrot. ex DC Decoction of leaf In vitro-Inhibit hepatitis B virus antigen (HBsAg)—Concentration for drug: 100–500 ng/mL Active [147]
C. racemosum P. Beauv Hot H2O ext. of dried leaf Abortion in 7 days after oral administration of 10 g/mL in pregnant guinea pig Active [151]
Embryotoxic
C. molle R. Br. ex G. Don Hot H2O ext. of dried entire plant Rats treated with extract in dose of 10.0 mg/kg (p.o.) Inactive [79]
Gastrintestinal activity
Gastric antiulcer
C. dolichopetalum EtOH (70%) ext. of dried root Pyloric ligation together with histamine-induced ulcers and gastric secretions in rats—Dose for drug: 400.0 mg/kg (p.o.) Active [93]
EtOH (16%) ext. of dried root Indomethacin and cold strees-induced ulcers in guinea pig—Dose for drug: 100.0 mg/kg (p.o.) Active [94]
C. duarteanum Cambess EtOH or Hexane ext. of dried leaf HCl/Ethanol, piroxican or immobilization-cold strees-induced ulcers in mice—Dose for drug: 62.5, 125, 250 and 500 mg/kg (p.o.) Active [163]
C. leprosum Mart. & Eiche EtOH ext. of dried stem bark Ethanol or Indomethacin induced gastric ulcer in rats—Doses for drug: 60, 125 and 250 mg/kg (p.o.) Active [164]
Gastric emptying
C. dolichopetalum Gils ex Engl. EtOH (70%) ext. of dried root Delayed gastric emptying in rat—Dose for drug: 400.0 mg/kg (p.o.) Active [93]
Antispasmodic
C. ovalifolium var.cooperi EtOH-H2O (1:1) ext. of aerial parts Ach and histamine-induced contractions in guinea pig ileum—Concentration not cited Active [152]
C. racemosum P. Beauv Hot H2O ext. of dried leaf Ach, nicotine or histamine-induced contractions in guinea pig ileum—Concentration for drug:1.0g/mL Active [151]
Spontaneous contractions in rabbit jejunum blocked by DHE and propranolol—Concentration for drug: 0.2–1 g/mL Inactive [151]
C. dolichopetalum Gils ex Engl. EtOH (70%) ext. of dried root Ach or histamine-induced contractions in guinea pig ileum—Concentration for drug: 0.24 μg/mL Active [93]
Ach or histamine-induced contractions in guinea pig ileum—Concentration for drug: 10 μg/mL Active [94]
Relaxation effect in guinea pig ileum—EC50 for drug: 2.65 mg/mL Active [94]
Geniturinary activity
C. erythrophyllum (Burch.) Sond. H2O or EtOH (95%) ext. of dried leaf In vitro-Radioactivity of cyclooxygenase (prepared from sheep seminal vesicle microsomal fractions)—Concentration for drugs: 20.0 mg/mL or 2.5 mg/mL, respectively Active [92]
H2O or EtOH (95%) ext. of dried leaf Ach-induced contractility uterine in guinea pig—Dose for drugs: 10 mg/mL Active [92]
Oxytocin-induced contractility uterine in guinea pig—Dose for drugs: 10 mg/mL Inactive [92]
Hot H2O ext. of dried branch and leaf In vitro-Contractions of uterus isolated from rat—Concentration not cited Active [165]
C. kraussii Hochst. Hot H2O ext. of dried root In vitro-Contractions of uterus isolated from rat—Concentration not cited Active [165]
C. nanum Ham. ex. D. Don. EtOH/H2O (1:1) ext. of dried entire plant Spermicidal effect in rat—Concentration not cited Inactive [162]
C. platypetalum Sond. H2O or EtOH (95%) ext. of dried leaf In vitro-Radioactivity of cyclooxygenase (prepared from sheep seminal vesicle microsomal fractions)—Concentration for drugs: 20.0 mg/mL or 2.5 mg/mL, respectively Active [92]
Ach or oxytocin-induced contractility uterine in guinea pig—Dose for drugs: 10 mg/mL Inactive [92]
C. racemosum P. Beauv Hot H2O ext. of dried leaf In vitro-Contractions in guinea pig gravid and non-gravid uterus blocked by hydergine—Concentration for drug: 1–2 g/mL Inactive [151]
Ext. induced spontaneus contractions in guinea pig vas deferens—Concentration for drug: 0.5 g/mL Active [151]
C. zeyheri Sond. H2O or EtOH (95%) ext. of dried bark Radioactivity of cyclooxygenase (prepared from sheep seminal vesicle microsomal fractions)—Concentration for drugs: 20.0 mg/mL or 2.5 mg/mL, respectively Active [92]
Ach or oxytocin-induced contractility uterine in guinea pig—Dose for drugs: 10 mg/mL Inactive [92]

i.p. = intraperitoneal; p.o. = oral; i.v. = intravenous; EtOH ext. = ethanolic extract; H2O ext. = aqueous extract; MeOH ext. = methanolic extract; EtOAc ext. = ethyl acetate extract; CHCl3 ext. = chloroformic extract; CCl4 ext. = carbon tetrachloride extract; MeCl2 ext. = dichloromethane extract; EtOH/H2O ext. = crude aqueous/alcoholic extract; MeOH/H2O ext. = aqueous/methanolic extract; CHCl3/MeOH ext. = chloroformic and methanolic extract; MeOH/MeCl2 ext. = methanolic/dichloromethane extract; Pet ether ext. = Petroleum ether extract. Ach = Acethylcholine; DHE = Dihydroergotamine; ACE = Angiotensin converting enzyme.

 4. Conclusions

The research papers cited in this review contribute to justifying the traditional use of the genus Combretum for the treatment of various health problems. This genus presents itself as a promising new scientific research topic to investigate the pharmacological potential of the extracts, fractions and compounds isolated from plant species of this genus.

We see that there is a need for further studies on the standardization or chemical characterization of the extracts used and for other more detailed phytochemical studies. With respect to pharmacological studies, there is an increasing need for further in vivo investigations of toxicity and biological activities, as well as for insights into the possible mechanisms involved. Therefore, new research findings could lead to greater safety and benefits to people who use these species to treat diseases, contributing to a better access to health care and thereby a better quality of life.

Acknowledgements

The authors thank the University of Illinois at Chicago, USA for the use of the NAPRALERT database for this study and A. Leyva for the English revision of the manuscript. Thanks are in order also for the financial support provided by CAPES/CNPq/PRONEX-FAPESQ.

References Hoareau L. Da Silva E.J. Medicinal plants: A re-emerging health aid Eletron. J. Biotechnol. 1999 2 56 70 Edeoga H.O. Okwu D.E. Mbaebie B.O. Phytochemical constituents of some Nigerian medicinal plants Afr. J. Biotechnol. 2005 4 685 688 Agra M.F. Freitas P.F. Barbosa-Filho J.M. Synopsis of the plants known as medicinal and poisonous in Northeast of Brazil Rev. Bras. Farmacogn. 2007 17 114 140 10.1590/S0102-695X2007000100021 Atindehou K.K. Schmid C. Brun R. Koné M.W. Traore D. Antitrypanosomal and antiplasmodial activity of medicinal plants from Côte d’Ivoire J. Ethnopharmacol. 2004 90 221 227 10.1016/j.jep.2003.09.032 Muthu C. Ayyanar M. Raja N. Ignacimuthu S. Medicinal plants used by traditional healers in Kancheepuram District of Tamil Nadu, India J. Ethnobiol. Ethnomed. 2006 2 Gansané A. Sanon S. Ouattara L.P. Traoré A. Hutter S. Ollivier E. Azas N. Traore A.S. Guissou I.P. Sirima S.B. Antiplasmodial activity and toxicity of crude extracts from alternatives parts of plants widely used for the treatment of malaria in Burkina Faso: Contribution for their preservation Parasitol. Res. 2010 106 335 340 10.1007/s00436-009-1663-y19921259 Pietrovski E.F. Rosa K.A. Facundo V.A. Rios K. Marques M.C.A. Santos A.R.S. Antinociceptive properties of the ethanolic extract and of the triterpene 3β,6β,16β-trihidroxilup-20(29)-ene obtained from flowers of Combretum leprosum in mice Pharmacol. Biochem. Behav. 2006 83 90 99 10.1016/j.pbb.2005.12.010 Rogers C.B. Verotta L. Chemistry and Biological Properties of the African Combretaceae Chemistry, Biological and Pharmacological Properties of African Medicinal Plants Hostettman K. Chinyanganga F. Maillard M. Wolfender J.L. University of Zimbabwe Publications Harare, Zimbabwe 1996 Bisoli E. Garcez W.S. Hamerski L. Tieppo C. Garcez F.R. Bioactive pentacyclic triterpenes from the stems of Combretum laxum Molecules 2008 13 2717 2728 10.3390/molecules13112717 Banskota A.H. Tezuka Y. Kim Q.T. Tanaka K. Saiki L. Kadota S. Thirteen novel cycloartane-type triterpenes from Combretum quadrangulare J. Nat. Prod. 2000 63 57 64 10.1021/np990336q10650080 Ogan A.U. The alkaloids in the leaves of Combretum micranthum. Studies on West African medicinal plants. VII Planta Med. 1972 21 210 217 10.1055/s-0028-1099545 Martini N.D. Katerere D.R.P. Eloff J.N. Biological activity of five antibacterial flavonoids from Combretum erythrophyllum (Combretaceae) J. Ethnopharmacol. 2004 93 207 212 10.1016/j.jep.2004.02.030 Aderogba M.A. Kgatle D.T. McGaw L.J. Eloff J.N. Isolation of antioxidant constituents from Combretum apiculatum subsp apiculatum. South Afr. J. Bot. 2012 79 125 131 10.1016/j.sajb.2011.10.004 Chaabi M. Benayache S. Benayache F. N’Gom S. Koné M. Anton R. Weniger B. Lobstein A. Triterpenes and polyphenols from Anogeissus leiocarpus (Combretaceae) Biochem. Systemat. Ecol. 2008 36 59 62 10.1016/j.bse.2007.05.007 Fyhrquist P. Mwasumbi L. Vuorela P. Vuorela H. Hiltunen R. Murphy C. Adlercreutz H. Preliminary antiproliferative effects of some species of Terminalia, Combretum and Pteleopsis collected in Tanzania on some human cancer cell lines Fitoterapia 2006 77 358 366 10.1016/j.fitote.2006.05.017 Moura M.D. Silva J.S. Oliveira R.A.G. Diniz M.F.F.M. Barbosa-Filho J.M. Natural products reported as potential inhibitors of uterine cervical neoplasia Acta Farm. Bonaerense 2002 21 67 74 Silva J.S. Moura M.D. Oliveira R.A.G. Diniz M.F.F. Barbosa-Filho J.M. Natural product inhibitors of ovarian neoplasia Phytomedicine 2003 10 221 232 10.1078/094471103321659988 Quintans-Júnior L.J. Almeida J.R.G.S. Lima J.T. Nunes X.P. Siqueira J.S. Oliveira L.E.G. Almeida R.N. Athayde-Filho P.F. Barbosa-Filho J.M. Plants with anticonvulsant properties—A review Rev. Bras. Farmacogn. 2008 18 798 819 10.1590/S0102-695X2008000500026 Sousa F.C.F. Melo C.T.V. Citó M.C.O. Félix F.H.C. Vasconcelos S.M.M. Fonteles M.M.F. Barbosa-Filho J.M. Viana G.S.B. Plantas medicinais e seus constituintes bioativos: Uma revisão da bioatividade e potenciais benefícios nos distúrbios da ansiedade em modelos animais Rev. Bras. Farmacogn. 2008 18 642 654 10.1590/S0102-695X2008000400023 Almeida R.N. Navarro D.S. Barbosa-Filho J.M. Plants with central analgesic activity Phytomedicine 2001 8 310 322 10.1078/0944-7113-00050 Pereira J.V. Modesto-Filho J. Agra M.F. Barbosa-Filho J.M. Plant and plant-derived compounds employed in prevention of the osteoporosis Acta Farm. Bonaerense 2002 21 223 234 Rocha L.G. Almeida J.R.G.S. Macedo R.O. Barbosa-Filho J.M. A review of natural products with antileishmanial activity Phytomedicine 2005 12 514 535 10.1016/j.phymed.2003.10.006 Barbosa-Filho J.M. Nascimento-Júnior F.A. Tomaz A.C.A. Athayde-Filho P.F. Silva M.S. Cunha E.V.L. Souza M.F.V. Batista L.M. Diniz M.F.F.M. Natural products with antileprotic activity Rev. Bras. Farmacogn. 2007 17 141 148 10.1590/S0102-695X2007000100022 Lima G.R.M. Montenegro C.A. Almeida C.L.F. Athayde-Filho P.F. Barbosa-Filho J.M. Batista L.M. Database survey of anti-inflammatory plants in South America: A review Int. J. Mol. Sci. 2011 12 2692 2749 10.3390/ijms1204269221731467 Souto A.L. Tavares J.F. Silva M.S. Diniz M.F.F.M. Athayde-Filho P.F. Barbosa Filho J.M. Anti-inflammatory activity of alkaloids: An update from 2000 to 2010 Molecules 2011 16 8515 8534 10.3390/molecules16108515 Mariath I.R. Falcão H.S. Barbosa-Filho J.M. Sousa L.C.F. Tomaz A.C.A. Batista L.M. Diniz M.F.F.M. Athayde-Filho P.F. Tavares J.F. Silva M.S. Plants of the American continent with antimalarial activity Rev. Bras. Farmacogn. 2009 19 158 192 10.1590/S0102-695X2009000100026 Falcão H.S. Mariath I.R. Diniz M.F.F.M. Batista L.M. Barbosa-Filho J.M. Plants of the American continent with antiulcer activity Phytomedicine 2008 15 132 146 10.1016/j.phymed.2007.07.057 Mota K.S.L. Dias G.E.N. Pinto M.E.F. Luiz-Ferreira A. Souza-Brito A.R.M. Hiruma Lima C.A. Barbosa-Filho J.M. Batista L.M. Flavonoids with gastroprotective activity Molecules 2009 14 979 1012 10.3390/molecules14030979 Falcão H.S. Leite J.A. Barbosa-Filho J.M. Athayde-Filho P.F. Chaves M.C.O. Moura M.D. Ferreira A.L. Almeida A.B.A. Souza-Brito A.R.M. Diniz M.F.F.M. Gastric and duodenal antiulcer activity of alkaloids: A review Molecules 2008 13 3198 3223 10.3390/molecules1312319819104486 Jesus N.Z.T. Falcão H.S. Gomes I.F. Leite T.J.A. Lima G.R.M. Barbosa-Filho J.M. Tavares J.F. Silva M.S. Athayde-Filho P.F. Batista L.M. Tannins, peptic ulcer and related mechanisms Int. J. Mol. Sci. 2012 13 3203 3228 10.3390/ijms1303320322489149 Ribeiro-Filho J. Falcão H.S. Batista L.M. Barbosa Filho J.M. Piuvezam M.R. Effects of plant extracts on HIV-1 protease Curr. HIV Res. 2010 8 531 544 10.2174/157016210793499204 Agra M.F. Silva K.N. Basílio I.J.L.D. Freitas P.F. Barbosa-Filho J.M. Survey of medicinal plants used in the region Northeast of Brazil Rev. Bras. Farmacogn. 2008 18 472 508 10.1590/S0102-695X2008000300023 Silva F.L. Fischer D.C.H. Tavares J.F. Silva M.S. Athayde-Filho P.F. Barbosa-Filho J.M. Compilation of secondary metabolites from Bidens pilosa L Molecules 2011 16 1070 1102 10.3390/molecules16021070 Barbosa-Filho J.M. Alencar A.A. Nunes X.P. Tomaz A.C.A. Sena-Filho J.G. Athayde Filho P.F. Silva M.S. Souza M.F.V. Cunha E.V.L. Sources of alpha-, beta-, gamma-,delta- and epsilon-carotenes: A twentieth century review Rev. Bras. Farmacogn. 2008 18 135 154 10.1590/S0102-695X2008000100023 Alves J.S. Castro J.C.M. Freire M.O. Cunha E.V.L. Barbosa-Filho J.M. Silva M.S. Complete assignment of the 1H and 13C spectra of four triterpenes of the ursane, artane, lupine and friedelane groups Magn. Reson. Chem. 2000 38 201 206 10.1002/(SICI)1097-458X(200003)38:3<201::AID-MRC622>3.0.CO;2-0 Sena-Filho J.G. Duringer J. Maia G.L.A. Tavares J.F. Xavier H.S. da Silva M.S. da Cunha E.V.L. Barbosa-Filho J.M. Ecdysteroids from Vitex species: Distribution and compilation of their 13C-NMR spectral data Chem. Biodivers. 2008 5 707 713 10.1002/cbdv.20089006718493957 Oliveira S.L. Silva M.S. Tavares J.F. Sena-Filho J.G. Lucena H.F.S. Romero M.A.V. Barbosa-Filho J.M. Tropane alkaloids from genus Erythroxylum: Distribution and compilation of 13C-NMR spectral data Chem. Biodivers. 2010 7 302 326 10.1002/cbdv.200800290 Palmeira-Junior S.F. Conserva L.M. Barbosa Filho J.M. Clerodane diterpenes from Croton species: Distribution and a compilation of their and 13C-NMR Nat. Prod. Commun. 2006 1 319 344 Sena Filho J.G. Duringer J.M. Uchoa D.E.A. Xavier H.S. Barbosa Filho J.M. Braz Filho R. Distribution of iridoid glucosides in plants from the genus Lippia (Verbenaceae): An investigation of Lippia alba (Mill.) N.E. Brown Nat. Prod. Commun. 2007 2 715 716 Lira N.S. Montes R.C. Tavares J.F. Silva M.S. Cunha E.V.L. Athayde-Filho P.F. Rodrigues L.C. Dias C.S. Barbosa-Filho J.M. Brominated compounds from marine sponges of the genus Aplysina and a compilation of their 13C-NMR spectral data Mar. Drugs 2011 9 2316 2368 10.3390/md911231622163189 Honório Júnior J.E.R. Soares P.M. Melo C.L. Arruda Filho A.C.V. Sena Filho J.G. Barbosa-Filho J.M. Sousa F.C.F. Fonteles M.M.F. Leal L.K.A. Queiroz M.G.R. Atividade farmacológica da monocrotalina isolada de plantas do gênero Crotalaria Rev. Bras. Farmacogn. 2010 20 453 458 10.1590/S0102-695X2010000300025 Vasconcelos S.M.M. Honório-Júnior J.E.R. Abreu R.N.D.C. Silva M.C.C. Barbosa-Filho J.M. Lobato R.F.G. Pharmacologic Study of Some Plant Species from the Brazilian Northeast: Calotropis procera, Agava sisalana, Solanum paludosum, Dioscorea cayenensis and Crotalaria retusa Medicinal Plants: Classification, Biosynthesis and Pharmacology Varela A. Ibañez J. Nova Science Publishers, Inc. New York, NY, USA 2009 4 189 202 Vasconcelos S.M.M. Pereira E.C. Chaves E.M.C. Lobato R.F.G. Barbosa-Filho J.M. Patrocínio M.C.A. Pharmacologic Study of Amburana cearensis and Aniba genus Recent Progress in Medicinal Plants. Drug Plant IV Singh V.K. Govil J.N. Studium Press LLC Houston, TX, USA 2010 30 51 64 Barbosa-Filho J.M. Sette I.M.F. Cunha E.V.L. Guedes D.N. Silva M.S. Protoberberine Alkaloids The Alkaloids Cordell G.A. Elsevier Amsterdam, The Netherlands 2005 62 1 75 Conserva L.M. Pereira C.A.B. Barbosa-Filho J.M. Alkaloids of the Hernandiaceae: Occurrence and a Compilation of Their Biological Activities The Alkaloids Cordell G.A. Elsevier Amsterdam, The Netherlands 2005 62 175 243 Barbosa-Filho J.M. Cunha E.V.L. Gray A.I. Alkaloids of the Menispermaceae The Alkaloids Cordell G.A. Academic Press San Diego, CA, USA 2000 54 1 199 Almeida C.L.F. Falcão H.S. Lima G.R.M. Montenegro C.A. Lira N.S. Athayde-Filho P.F. Rodrigues L.C. Souza M.F.V. Barbosa-Filho J.M. Batista L.M. Bioactivities from marine algae of the genus Gracilaria Int. J. Mol. Sci. 2011 12 4550 4573 10.3390/ijms1207455021845096 Le Grand A. Wondergem P.A. Antiinfective phytotherapy of the savannah forests of Senegal (East Africa) I. An inventory J. Ethnopharmacol. 1987 21 109 125 10.1016/0378-8741(87)90122-X Le Grand A. Anti-infectious phytotherapy of the tree-savannah, Senegal (Western Africa) III: A review of the phytochemical substances and anti-microbial activity of 43 species J. Ethnopharmacol. 1989 25 315 338 10.1016/0378-8741(89)90037-8 Comley J.C.W. New macrofilaricidal leads from plants? Trop. Med. Parasitol. 1990 41 1 9 2187223 Tignokpa M. Laurens A. Mboup S. Sylla O. Popular medicinal plants of the markets of Dakar (Senegal) Int. J. Crude. Drug. Res. 1986 24 75 80 Malcolm S.A. Sofowora E.A. Antimicrobial activity of selected Nigerian folk remedies and their constituent plants Lloydia 1969 32 512 517 5374040 Laurens A. Mboup S. Tignokpa M. Sylla O. Masquelier J. Antimicrobial activity of some medicinal species of Dakar markets Pharmazie 1985 40 482 485 4048256 Le Grand A. Wondergem P.A. Verpoorte R. Pousset J.L. Anti-infectious phytotherapies of the tree-savannah of Senegal (West-Africa). Antimicrobial activity of 33 species J. Ethnopharmacol. 1988 22 25 31 10.1016/0378-8741(88)90227-9 Bassene E. Mahamat B. Lo M. Boye C.S.B. Faye B. Comparison of the antibacterial activity of three Combretaceae: Combretum micranthum, Guiera senegalensis and Terminalia avicennioides Fitoterapia 1995 66 86 88 Adoum A.O. Dabo N.T. Fatope M.O. Bioactivities of some savanna plants in the brine shrimp lethality test and in vitro antimicrobial assay Int. J. Pharmacog. 1997 35 334 337 10.1080/09251619708951278 Abreu P.M. Martins E.S. Kayser O. Bindseil K.U. Siems K. Seemann A. Frevert J. Antimicrobial, antitumor and antileischmania screening of medicinal plants from Guinea-Bissau Phytomedicine 1999 6 187 195 10.1016/S0944-7113(99)80008-7 Ferrea G. Canessa A. Sampietro F. Cruciani M. Romussi G. Bassetti D. In vitro activity of a Combretum micranthum extract against Herpes simplex virus types 1 and 2 Antiviral Res. 1993 21 317 325 10.1016/0166-3542(93)90010-G Benoit F. Valentin A. Pelissier Y. Diafouka F. Marion C. Kone-Bamba D. Kone M. Mallie M. Yapo A. Bastide J.M. In vitro antimalarial activity of vegetal extracts used in west african traditional medicine Am. J. Trop. Med. Hyg. 1996 54 67 71 8651373 Karou D. Dicko M.H. Sano S. Simpore J. Traore A.S. Antimalarial activity of Sida acuta Burm. F. (Malvaceae) and Pterocarpus erinaceus Poir. (Fabaceae) J. Ethnopharmacol. 2003 89 291 294 10.1016/j.jep.2003.09.010 Ancolio C. Azas N. Mahiou V. Ollivier E. di Giorgio C. Keita A. Timon-David P. Balansard G. Antimalarial activity of extracts and alkaloids isolated from six plants used in traditional medicine in Mali and Sao Tome Phytother. Res. 2002 16 466 469 Di Carlo F.J. Haynes L.J. Sliver N.J. Phillips G.E. Reticuloendothelial system stimulants of botanical origin J. Reticuloendothel. Soc. 1964 1 224 Chika A. Bello S.O. Antihyperglycaemic activity of aqueous leaf extract of Combretum micranthum (Combretaceae) in normal and alloxan-induced diabetic rats J. Ethnopharmacol. 2010 129 34 37 10.1016/j.jep.2010.02.008 Keay R.W.J. Trees of Nigeria. Clarendon Press Oxford, UK 1989 3 146 216 McGaw L.J. Jager A.K. Staden J.V. Antibacterial, anthelmintic and anti-amoebic activity in South African medicinal plants J. Ethnopharmacol. 2000 72 247 263 10.1016/S0378-8741(00)00269-5 Fyhrquist P. Mwasumbi L. Haeggstrom C. Vourela H. Hiltunem R. Vurela P. Ethnobotanical and antimicrobial investigation on some species of Terminalia and Combretum (Combretaceae) growing in Tanzania J. Ethnopharmacol. 2002 79 169 177 10.1016/S0378-8741(01)00375-0 Bussmann R.W. Gilbreath G.G. Soilo J. Lutura M. Lutuluo R. Kunguru K. Wood N. Mathenge S.G. Plant use of the Massai of Sekenani Valley, Massai Mara, Kenya J. Ethnobiol. Ethnomed. 2006 2 Grønhaug T.E. Glæserud S. Skogsrud M.. Ballo N. Bah S. Diallo D. Pualsen B.S. Ethnopharmacological survey of six medicinal plants from Mali, West Africa J. Ethnobiol. Ethnomed. 2008 4 Eloff J.N. A sensitive and quick microplate method to determine the minimal inhibitory concentration of plant extracts for bacteria Planta Med. 1998 64 711 713 10.1055/s-2006-957563 Geyid A. Abebe D. Debella A. Makonnen Z. Aberra F. Teka F. Kebede T. Urga K. Yersaw K. Biza T. Screening of some medicinal plants of Ethiopia for their anti-microbial properties and chemical profiles J. Ethnopharmacol. 2005 97 421 427 10.1016/j.jep.2004.08.021 Njume C. Jide A.A. Ndip R.N. Aqueous and organic solvent-extracts of selected South African medicinal plants possess antimicrobial activity against drug-resistant strains of Helicobacter pylori: Inhibitory and bactericidal potential Int. J. Mol. Sci. 2011 12 5652 5665 10.3390/ijms12095652 Baba-Moussa F. Akpagana K. Bouchet P. Antifungal activities of seven West African Combretaceae used in traditional medicine J. Ethnopharmacol. 1999 66 335 338 10.1016/S0378-8741(98)00184-6 Masoko P. Picard J. Eloff J.N. The antifungal activity of twenty-four Southern African Combretum species (Combretaceae) South Afr. J. Bot. 2007 73 173 183 10.1016/j.sajb.2006.09.010 Lall N. Meyer J.J.M. In vitro inhibition of drug-resistant and drug-sensitive strains of Mycobacterium tuberculosis by ethnobotanically selected South African plants J. Ethnopharmacol. 1999 66 347 354 10.1016/S0378-8741(98)00185-8 Kloos H. Thiongo F.W. Ouma J.H. Butterworth A.E. Preliminary evaluation of some wild and cultivated plants for snail control in Machakos District, Kenya J. Trop. Med. Hyg. 1987 90 197 204 3656497 Asres K. Bucar F. Knauder E. Yardley V. Kendrick H. Croft S.L. In vitro antiprotozoal activity of extract and compounds from the stem bark of Combretum molle Phytother. Res. 2001 15 613 617 10.1002/ptr.897 Ademola I.O. Eloff J.N. In vitro anthelmintic activity of Combretum molle (R. Br. ex G. Don) (Combretaceae) against Haemonchus contortus ova and larvae Vet. Parasitol. 2010 169 198 203 10.1016/j.vetpar.2009.12.036 Asres K. Balcha F. Phytochemical screening and in vitro antimalarial activity of the stem bark of Combretum molle R. Br. ex G. Don Ethiopian Pharm. J. 1998 16 25 33 Osore H. Screening of selected medicinal plants for novel female regulating agents Fitoterapia 1987 58 345 346 Bessong P.O. Obi C.L. Andréola M.L. Rojas L.B. Pouységu L. Igumbor E. Meyer J.J.M. Quideau S. Litvak S. Evaluation of selected South African medicinal plants for inhibitory properties against human immunodeficiency virus type 1 reverse transcriptase and integrase J. Ethnopharmacol. 2005 99 83 91 10.1016/j.jep.2005.01.056 Ojewole J.A.O. Analgesic and anti-inflammatory effects of mollic acid glucoside, a 1a-hydroxycycloartenoid saponin extractive from Combretum molle R. Br. ex G. Don (Combretaceae) leaf Phytother. Res. 2008 22 30 35 10.1002/ptr.2253 Ojewole J.A.O. Cardiovascular effects of mollic acid glucoside, a 1alpha-hydroxycycloartenoid saponin extractive from Combretum molle R Br. ex G. Don (Combretaceae) leaf Cardiovasc. J. Afr. 2008 19 128 134 18568171 Ojewole J.A.O. Adewole S.O. Hypoglycaemic effect of mollic acid glucoside, a 1a-hydroxycycloartenoid saponin extractive from Combretum molle R. Br. ex G. Don (Combretaceae) leaf, in rodents J. Nat. Med. 2009 63 117 123 10.1007/s11418-008-0298-0 Asres K. Bucar F. Anti-HIV activity against immunodeficiency virus type 1 (HIV-I) and type II (HIV-II) of compounds isolated from the stem bark of Combretum molle Ethiop. Med. J. 2005 43 15 20 16370525 Gelfand M. Mavis S. Drummond R.B. Ndemera B. The Traditional Medical Practitioner in Zimbabwe Mambo Press Gweru, Zimbabwe 1985 Sohni Y.R. Kale P.G. Mutagenicity of Combretum erythrophyllum in sex-linked recessive lethal test in Drosophila Phytother. Res. 1997 11 524 526 10.1002/(SICI)1099-1573(199711)11:7<524::AID-PTR142>3.0.CO;2-V Hutchings A. Scott A.H. Lewis G. Cunningham A.B. Zulu Medicinal Plants: An Inventory University of Natal Press Pietermaritzburg, South Africa 1996 Martini N. Eloff J.N. The preliminary isolation of several antibacterial compounds from Combretum erythrophyllum (Combretaceae) J. Ethnopharmacol. 1998 62 255 263 10.1016/S0378-8741(98)00067-1 Eloff J.N. It is possible to use herbarium specimens to screen for antibacterial components in some plants J. Ethnopharmacol. 1999 67 355 360 10.1016/S0378-8741(99)00053-7 Sohni Y.R. Mutangadura-Mhlanga T. Kale P.G. Bacterial mutagenicity of eight medicinal herbs from Zimbabwe Mutat. Res. 1994 322 133 140 10.1016/0165-1218(94)00021-2 Schwikkard S. Xhou B.N. Glass T.E. Sharp J.L. Mattern M.R. Johnson R.K. Kingston D.G.I. Bioactive compounds from Combretum erythrophyllum J. Nat. Prod. 2000 63 457 460 10.1021/np9904410 Lindsey K. Jager A.K. Raidoo D.M. van Staden J. Screening of plants used by Southern African traditional healers in the treatment of dysmenorrhoea for prostaglandin–synthesis inhibitors and uterine relaxing activity J. Ethnopharmacol. 1999 64 9 14 10075117 Asuzu I.U. Njoku J.C. The pharmacological properties of the ethanolic root extract of Combretum dolichopetalum Phytother. Res. 1992 6 125 128 10.1002/ptr.2650060304 Asuzu I.U. Onu O.U. Anti-ulcer activity of the ethanolic extract of Combretum dolichopetalum roots Int. J. Crude Drug Res. 1990 28 27 32 Udem S.C. Madubunyi I. Okoye J.O.A. Anika S.M. Anti-hepatotoxic effects of the ethanolic extracts of Combretum dolichopetalum root bark and Morinda lucida leaf Fitoterapia 1997 68 21 24 Asuzu I.U. Adimorah R.I. The antiinflamatory activity of extracts from the root of Combretum dolichopetalum Phytomedicine 1998 5 25 28 10.1016/S0944-7113(98)80055-X Udem S.C. Madubunyi I. Asuzu I.U. Anika S.M. The trypanocidal action of the root extract of Combretum dolichopetalum Fitoterapia 1996 67 31 37 Lecompte O. Museum National d’Histoire Naturalle Flore du Cambodge, du Laos et du Vietnam 1969 58 61 Somanabandhu A. Wungchinda S. Wiwat C. Chemical Composition of Combretum Quadrangulare Kurz 4th Asian Symp. Med. Plants Spices Bangkok, Thailand 1980 Ohsugi M. Basnet P. Kadota S. Ishii E. Tamura T. Okumura Y. Namba T. Antibacterial activity of traditional medicines and an active constituent lupulone from Humulus lupulus against Helicobacter pylori J. Tradit. Med. 1997 14 186 191 Adnyana L.K. Tezuka Y. Banskota A.H. Tran K.Q. Kadota S. Hepatoprotective constituents of the seeds of Combretum quadrangulare Biol. Pharm. Bull. 2000 23 1328 1332 10.1248/bpb.23.1328 Kiuchi F. Matsuo K. Itano Y. Ito M. Honda G. Oui TK. Nakajima Shimada J. Aoki T. Screening of natural medicines used in Vietnam for trypanocidal activity against epimastigotes of Trypanosoma cruzi Nat. Med. 2002 56 64 68 Tewtrakul S. Miyashiro H. Nakamura N. Hattori M. Kawahata T. Otake T. Yoshinaga T. Fujiwara T. Supavita T. Yuenyongsawad S. HIV-1 integrase inhibitory substances from Coleus parvifolius Phytother. Res. 2003 17 232 239 10.1002/ptr.1111 Adnyana I.K. Tezuka Y. Awale S. Banskota A.H. Tran K.Q. Kadota S. 1-O-galloyl-6-O-(4-hydroxy-3,5-dimethoxy)benzoyl-beta-D-glucose, a new hepatoprotective constituent from Combretum quadrangulare Planta Med. 2001 67 370 371 10.1055/s-2001-14318 Adnyana I.K. Tezuka Y. Banskota A.H. Tran K.Q. Kadota S. Three New triterpenes from the seeds of Combretum quadrangulare and their hepatoprotective activity J. Nat. Prod. 2001 64 360 363 10.1021/np000486x Eldeen I.M.S. Vas Staden J. In vitro pharmacological investigation of extracts from some trees used in Sudanese traditional medicine South Afr. J. Bot. 2007 73 435 440 10.1016/j.sajb.2007.03.009 Braga F.C. Wagner H. Lombardi J.A. De Oliveira A.B. Screening the Brazilian flora for antihypertensive plant species for in vitro angiotensin-I-converting enzyme inhibiting Phytomedicine 2000 7 245 250 10.1016/S0944-7113(00)80011-2 Serra C.P. Côrtes S.F. Lombardi J.A. Braga de Oliveira A. Braga F.C. Validation of a colorimetric assay for the in vitro screening of inhibitors of angiotensin-converting enzyme (ACE) from plant extracts Phytomedicine 2005 12 424 432 10.1016/j.phymed.2004.07.002 Braga F.C. Serra C.P. Viana N.S. Jr. Oliveira A.B. Côrtes S.F. Lombardi J.A. Angiotensin-converting enzyme inhibition by Brazilian plants Fitoterapia 2007 78 353 358 10.1016/j.fitote.2007.02.00717513067 Wall M.E. Wani M.C. Brown D.M. Fullas F. Oswald J.B. Josephson F.F. Thornton N.M. Pezzuto J.M. Beecher C.W.W. Farnsworth N.R. Effect of tannins on screening of plant extracts for enzyme inhibitory activity and techniques for their removal Phytomedicine 1996 3 281 285 10.1016/S0944-7113(96)80067-5 Ampofo O.F. Plants that heal World Health 1977 26 30 McGaw L.J. Rabe T. Sparg S.G. Jager A.K. Eloff J.N. Van Staden J. An investigation on the biological activity of Combretum species J. Ethnopharmacol. 2001 75 45 50 10.1016/S0378-8741(00)00405-0 Simon M.K. Ajanusi O.J. Abubakar M.S. Idris A.L. Suleiman M.M. The anthelmintic effect of aqueous methanol extract of Combretum molle (R. Br. x. G. Don) (Combretaceae) in lambs experimentally infected with Haemonchus contortus Vet. Parasitol. 2012 Sofowora E.A. Fip sections special: Section for the study of medicinal plants. V. West African traditional plant medicines Pharm. Int. 1982 3 137 Waterman C. Smith R.A. Pontiggia L. DerMarderosian A. Anthelmintic screening of Sub Saharan African plants used in traditional medicine J. Ethnopharmacol. 2010 127 755 759 10.1016/j.jep.2009.11.025 Lamidi M. DiGiorgio C. Delmas F. Favel A. Eyele Mve-Mba C. Rondi M.L. Ollivier E. Nze-Ekekang L. Balansard G. In vitro cytotoxic, antileishmanial and antifungal activities of ethnopharmacologically selected Gabonese plants J. Ethnopharmacol. 2005 102 185 190 10.1016/j.jep.2005.06.011 Gessler M.C. Nkunyak M.H.H. Mwasumbi L.B. Heinrich M. Tanner M. Screening Tanzanian medicinal plants for antimalarial activity Acta Tropica. 1994 56 65 77 10.1016/0001-706X(94)90041-8 Clarkson C. Maharaj V.J. Crouch N.R. Grace O.M. Pillay P. Matsabisa M.G. Bhagwandin N. Smith P.J. Folb P.I. In vitro antiplasmodial activity of medicinal plants native to or naturalised in South Africa J. Ethnopharmacol. 2004 92 177 191 10.1016/j.jep.2004.02.011 Elsheikh S.H. Bashir A.K. Suliman S.M. Wassila M.E. Toxicity of certain Sudanese plant extracts on cercariae and miracidia of Schistosoma mansoni Int. J. Crude. Drug. Res. 1990 28 241 245 Sparg S.G. Van Staden J. Jager A.K. Efficiency of traditionally used South African plants against schistosomiasis J. Ethnopharmacol. 2000 73 209 214 10.1016/S0378-8741(00)00310-X Bizimana N. Tietjen U. Zessin K.H. Diallo D. Djibril C. Melzig M.F. Clausen P.H. Evaluation of medicinal plants from Mali for their in vitro and in vivo trypanocidal activity J. Ethnopharmacol. 2006 103 350 356 10.1016/j.jep.2005.08.023 Cepleanu F. Hamburger M.O. Sordat B. Msonthi J.D. Gupta M.P. Saadou M. Hostettmann K. Screening of tropical medicinal plants for mulluscicidal, larvicidal, fungicidal and cytotoxic activities and brine shrimp toxicity Int. J. Pharmacog. 1994 32 294 307 10.3109/13880209409083007 Odda J. Kristensen S. Kabasa J. Waako P. Larvicidal activity of Combretum collinum Fresen against Aedes aegypti J. Vector. Borne Dis. 2008 45 321 324 19248660 Olukoya D.K. Idika N. Odugbemi T. Antibacterial activity of some medicinal plants from Nigeria J. Ethnopharmacol. 1993 39 69 72 10.1016/0378-8741(93)90051-6 Eloff J.N. Which extractant should be used for the screening and isolation of antimicrobial components from plants J. Ethnopharmacol. 1998 60 1 8 10.1016/S0378-8741(97)00123-2 Eldeen I.M.S. Vas Staden J. Cyclooxygenase inhibition and antimycobacterial effects of extracts from Sudanese medicinal plants South Afr. J. Bot. 2008 74 225 229 10.1016/j.sajb.2007.11.009 Angeh J.E. Huang X. Sattler I. Swan G.E. Dahse H. Härtl A. Eloff J.N. Antimicrobial and anti-inflammatory activity of four known and one new triterpenoid from Combretum imberbe (Combretaceae) J. Ethnopharmacol. 2007 110 56 60 10.1016/j.jep.2006.09.002 Asres K. Bucar F. Edelsbrunner S. Kartnig T. Hoger G. Thiel W. Investigation on antimycobacterial activity of some Ethiopian medicinal plants Phytother. Res. 2001 15 323 326 10.1002/ptr.724 Khan M.N. Ngassapa O. Matee M.I.N. Antimicrobial activity of Tanzanian chewing sticks against oral pathogenic microbes Pharm. Biol. 2000 38 235 230 21214468 Steenkamp V. Fernandes A.C. Van Rensburg C.E.J. Antibacterial activity of Venda medicinal plants Fitoterapia 2007 78 561 564 10.1016/j.fitote.2007.02.014 Regassa F. Araya M. In vitro antimicrobial activity of Combretum molle (Combretaceae) against Staphylococcus aureus and Streptococcus agalactiae isolated from crossbred dairy cows with clinical mastitis Trop. Anim. Health Prod. 2012 44 1169 1173 10.1007/s11250-011-0054-4 Desta B. Ethiopian traditional herbal drugs. Part II: Antimicrobial activity of 63 medicinal plants J. Ethnopharmacol. 1993 39 129 139 10.1016/0378-8741(93)90028-4 Mela C. Investigation of the presence of substances having antibiotic action in higher plants Fitoterapia 1950 21 98 99 Sawhney A.N. Khan M.R. Ndaalio G. Nkunya M.H.H. Wevers H. Studies on the rationale of African traditional medicine. Part II. Preliminary screening of medicinal plants for antigonoccoci activity Pak. J. Sci. Ind. Res. 1978 21 189 192 Almagboul A.Z. Bashir A.K. Karim A. Salih M. Farouk A. Khalid S.A. Antimicrobial activity of certain Sudanese plants used in folkloric medicine. Screening for antifungal activity (VI) Fitoterapia 1988 59 393 396 Steenkamp V. Fernandes A.C. Van Rensburg C.E.J. Screening of Venda medicinal plants for antifungal activity against Candida albicans South Afr. J. Bot. 2007 73 256 258 10.1016/j.sajb.2006.11.003 Sawhney A.N. Khan M.R. Ndaalio G. Nkunya M.H.H. Wevers H. Studies on the rationale of African traditional medicine. Part III. Preliminary screening of medicinal plants for antifungal activity Pak. J. Sci. Ind. Res. 1968 21 193 196 Pannangpetch P. Taejarernwiriyakul O. Kongyingyoes B. Ethanolic extract of Combretum decandrum Roxb. decreases blood glucose level and oxidative damage in streptozotocin-induced diabetic rats Diab. Res. Clin. Pract. 2008 79 107 108 Recio M.C. Giner R.M. Manez S. Rios J.L. Marston A. Hostettmann K. Screening of tropical medicinal plants for antiinflammatory activity Phytother. Res. 1995 9 571 574 10.1002/ptr.2650090807 Gouveia M.G. Xavier M.A. Barreto A.S. Gelain D.P. Santos J.P. Araújo A.A. Silva F.A. Quintans J.S. Agra M.F. Cabral A.G. Antioxidant, antinociceptive, and anti-inflammatory properties of the ethanolic extract of Combretum duarteanum in rodents J. Med. Food 2011 14 1389 1396 10.1089/jmf.2010.0212 Hiermann A. Bucar F. Influence of some traditional medicinal plants of Senegal on prostaglandin biosynthesis J. Ethnopharmacol. 1994 42 111 116 10.1016/0378-8741(94)90104-X Olajide O.A. Modupemakinde J. Okpako D.T. Evaluation of the anti-inflammatory property of the extract of Combretum micranthum G. Don (Combretaceae) Inflammopharmacology 2003 11 293 298 10.1163/156856003322315631 Lira S.R.S. Almeida R.N. Almeida F.R.C. Oliveira F.S. Duarte J.C. Preliminary studies on the analgesic properties of the ethanol extract of Combretum leprosum Pharm. Biol. 2002 40 213 215 10.1076/phbi.40.3.213.5837 Pettit G.R. Cragg G.M. Singh S.B. Antineoplastic agents, 122. Constituents of Combretum caffrum J. Nat. Prod. 1987 50 386 391 10.1021/np50051a008 George R.P. Gordon M.C. Delbert L.H. Jean M.S. Prasert L. Antineoplastic agents, 84. Isolation and structure of combretastatin Can. J. Chem. 1982 60 1374 1376 10.1139/v82-202 Ngaba J. Olschwang D. Giono-Barber H. Pousset J.L. African medicinal plants. III study of antitussive action of Combretum glutinosum Perr Ann. Pharm. Fr. 1980 38 529 536 7283351 Pousset J.L. Rey J.P. Levesque J. Coursaget P. Galen F.X. Hepatitis B surface antigen (HBSAG) inactivation and angiotensin-converting enzyme (ACE) inhibition in vitro by Combretum glutinosum Perr. (Combretaceae) extract Phytother. Res. 1993 7 101 102 10.1002/ptr.2650070126 Van Den Berghe D.A. Ieven M. Mertens F. Vlietinck A.J. Lammens E. Screening of higher plants for biological activities. II. Antiviral activity J. Nat. Prod. 1978 41 463 467 Asres K. Bucar F. Kartnig T. Witvrouw M. Pannecoupue C. de Clercq E. Antiviral activity against human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) of ethnobotanically selected Ethiopian medicinal plants Phytother. Res. 2001 15 62 69 10.1002/1099-1573(200102)15:1<62::AID-PTR956>3.0.CO;2-X Bamgbose S.O.A. Dramane K.L. Studies on Combretum species. II. Preliminary report on studies on four seeds of Combretum species Planta Med. Suppl. 1977 32 350 356 10.1055/s-0028-1097611 Akubue P.I. Mittal G.C. Aguwa C.N. Preliminary pharmacological study of some Nigerian medicinal plants 1 J. Ethnopharmacol. 1983 8 53 63 10.1016/0378-8741(83)90089-2 Dhar M.L. Dhar M.N. Dhawan B.N. Mehrotra B.N. Srimal R.C. Tandon J.S. Screening of Indian plants for biological activity. Part IV Indian. J. Exp. Biol. 1973 11 43 54 4779295 Nascimento S.C. Chiappeta A.A. Lima R.M.O.C. Antimicrobial and cytotoxic activities in plants from Pernambuco, Brazil Fitoterapia 1990 61 353 355 Nascimento S.C. de Mello J.F. Chiappeta A.A. Cytotoxic agents. Experiments with KB cells Rev. Inst. Antibiot. Univ. Fed. Pernambuco 1985 22 19 26 Simon G. Dewelle J. Nacoulma O. Guissou P. Kiss R. Daloze D. Braekman J.C. Cytotoxic pentacyclic triterpenes from Combretum nigricans Fitoterapia 2003 74 339 344 10.1016/S0367-326X(03)00046-7 Fouchea G. Cragg G.M. Pillay P. Kolesnikova N. Maharaj V.J. Senabe J. In vitro anticancer screening of South African plants J. Ethnopharmacol. 2008 119 455 461 10.1016/j.jep.2008.07.005 Massele A.Y. Nshimo C.M. Brine shrimp bioassay for biological activity of medicinal plants used in traditional medicines in Tanzania East Afr. Med. J. 1995 72 661 663 8904048 Sofowora E.A. Adewunmi C.O. Preliminary screening of some plant extracts for molluscicidal activity Planta Med. 1980 39 57 65 10.1055/s-2008-1074903 Adewunmi C.O. Natural products as agents of schistosomiasis control in Nigeria: A review of progress Int. J. Crude. Drug. Res. 1984 22 161 166 Sousa M.P. Rouquayrol M.Z. Molluscicidal activity of plants from Northeast Brazil Rev. Brasil. Pesq. Med. Biol. 1974 7 389 394 Bhakuni O.S. Dhar M.L. Dhar M.M. Dhawan B.N. Mehrotra B.N. Screening of Indian plants for biological activity. Part II Indian J. Exp. Biol. 1969 7 250 262 5359097 Dhawan B.N. Dubey M.P. Mehrotra B.N. Rastogi R.P. Tandon J.S. Screening of Indian plants for biological activity. Part IX Indian J. Exp. Biol. 1980 18 594 606 7439945 Lima G.R.M. Atividade gastroprotetora de Combretum duarteanum Cambess. (Combretaceae) em modelos animais Dissertation for the Programa de Pós-Graduação em Produtos Naturais e Sintéticos Bioativos avaliable at library (on-line) of Universidade Federal da Paraíba (UFPB): João Pessoa-Paraiba, Brazil, 2011. Nunes P.H.M. Cavalcanti P.M.S. Galvão S.M.P. Martins M.C.C. Antiulcerogenic activity of Combretum leprosum Pharmazie 2009 64 58 62 19216233 Brookes K.B. Doudoukina O.V. Katsoulis L.C. Veale D.J.H. Uteroactive constituents from Combretum kraussii South Afr. J. Chem. 1999 52 127 132